-
Publication Venue For
-
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer..
83:141-157.
2023
-
Challenges and Emerging Opportunities for Targeting mTOR in Cancer..
82:3884-3887.
2022
-
A Circle RNA Regulatory Axis Promotes Lung Squamous Metastasis via CDR1-Mediated Regulation of Golgi Trafficking..
80:4972-4985.
2020
-
Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines..
80:4314-4323.
2020
-
The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)..
80:1210-1218.
2020
-
Abstract 1194: Adoptive cellular therapy overcomes tumor-induced dysregulation of myelopoiesis.
79:1194-1194.
2019
-
Abstract 4075: Overcoming glioma immunoediting and MHC class I loss during adoptive cellular therapy.
79:4075-4075.
2019
-
An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer..
78:3823-3833.
2018
-
GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome..
77:5095-5106.
2017
-
Abstract IA08: Ataxia-telangiectasia: Broad implications from the study of a rare disease.
74:IA08-IA08.
2014
-
Abstract P1-08-20: Increased risk of hormone therapy failure in breast cancers expressing low phospho-Stat5: Validation of quantitative immunofluorescence assay parameters.
73.
2013
-
Abstract P4-06-03: Assays on core biopsies and surgically resected tumors may result in different subtyping of the invasive breast cancer from the same patient.
73.
2013
-
Abstract P4-06-09: HER2+ and HER2- luminal B subtypes have similar overall survival and histologic grade distributions.
73.
2013
-
Abstract P4-15-05: Novel targeted therapy for breast cancer chest wall recurrence: Low temperature liposomal doxorubicin and mild local hyperthermia.
73.
2013
-
Abstract P5-08-01: Systematic interrogation of resistance to HER2-directed therapy identifies a survival pathway activated by PRKACA and PIM1.
73.
2013
-
FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function..
73:6056-6067.
2013
-
Abstract 2409: A model of RAS pathway in colorectal cancer elucidates molecular traits and drug sensitivity: an integrated analysis of gene expression from human tumors, mouse xenografts and the Cancer Cell Line Encyclopedia (CCLE)..
73:2409-2409.
2013
-
Abstract 4517: Differential cellular response to nanoparticle docetaxel and docetaxel at sub-therapeutic dose range..
73:4517-4517.
2013
-
Abstract 4522: Nanoparticle chemosensitization..
73:4522-4522.
2013
-
Abstract 4530: Nanoparticle formulation of KU55933 as a potent radiosensitizer..
73:4530-4530.
2013
-
Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism..
73:1536-1546.
2013
-
Abstract PR3: The cholesterol metabolite 27-hydroxycholesterol increases breast cancer tumor growth and metastasis.
73:PR3-PR3.
2013
-
Abstract A29: An Ad5 [E1-, E2b-] platform carrying the TAA CEA(6D) induces CEA directed CMI responses in patients with advanced CEA-expressing colorectal cancer in a phase I/II clinical trial...
73:A29-A29.
2013
-
Abstract P2-10-03: A cross-platform comparison of genomic signatures and OncotypeDx score to discover potential prognostic/predictive genes and pathways.
72.
2012
-
Abstract P3-06-07: Ki67 as a Predictive Marker of Response to Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer (ESBC): A Systematic Review and Evidence Summary.
72.
2012
-
Abstract P4-08-07: Novel insight into the tumor “flare” phenomenon and lapatinib resistance.
72.
2012
-
Abstract P4-14-04: Total skin-sparing mastectomy in BRCA mutation carriers.
72.
2012
-
Abstract P4-16-07: Selective use of post-mastectomy radiation therapy in the neoadjuvant setting.
72.
2012
-
A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model..
72:6013-6023.
2012
-
Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells.
72:5625-5634.
2012
-
Abstract 1369: Mouse models of clinical oligo- and poly-metastatic progression.
72:1369-1369.
2012
-
Abstract 1678: European ancestry and ovarian cancer: Testing for their association using case control data.
72:1678-1678.
2012
-
Abstract 2012: MAP kinase activation and suppression of anti-apoptotic Bcl-2 family members are associated with induction of apoptotic death in melanoma cells following down-regulation of glutathione S-transferase P1.
72:2012-2012.
2012
-
Abstract 2162: EGFR-induced interaction of GSTP1 with the SH2-domain of Grb2 enhances Ras downstream activation in human glioma cells.
72:2162-2162.
2012
-
Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs in IL1A.
72:2603-2603.
2012
-
Abstract 2884: Preclinical studies on tumor retention, antitumor efficacy and toxicity of thermally responsive polypeptide-based radionuclide intratumoral depot in nude mice.
72:2884-2884.
2012
-
Abstract 2923: Androgen receptor activation changes chromatin structure and transcriptional activation.
72:2923-2923.
2012
-
Abstract 3035: Bone morphogenetic proteins signal through Smad2 and Smad3 to regulate cell migration and proliferation.
72:3035-3035.
2012
-
Abstract 3220: The effects of cholesterol treatment drugs alone and in combination on prostate tumor xenograft growth.
72:3220-3220.
2012
-
Abstract 3405: MicroRNA expression characterizes oligometastasis(es).
72:3405-3405.
2012
-
Abstract 381: Non-invasive histology for early detection of cutaneous melanoma and pigmented lesions in vivo.
72:381-381.
2012
-
Abstract 4285: Visualizing cancer vaccine clearance in vivo
using magnetic resonance imaging.
72:4285-4285.
2012
-
Abstract 4311: EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
72:4311-4311.
2012
-
Abstract 4389: Impact of regulatory T cell depletion on dendritic cell-tumor fusion vaccine immunotherapy.
72:4389-4389.
2012
-
Abstract 4514: A comparison of two methodologies to quantify Thymidylate synthase for predicting survival in patients with colorectal cancer treated on CALGB 89803.
72:4514-4514.
2012
-
Abstract 4958: Identification of cis-regulatory elements in a BIM deletion polymorphism that regulate splicing and generation of non-apoptotic BIM isoforms.
72:4958-4958.
2012
-
Abstract 5123: An integrated genomics approach to identify novel drivers of oncogenic pathway activity in human cancer.
72:5123-5123.
2012
-
Abstract 530: Circulating γδ T cells are activated and depleted during progression of high-grade gliomas: Implications for γδ T cells therapy of GBM.
72:530-530.
2012
-
Abstract 5363: Aggregation rather than monoclonal expansion explains ovarian cancer spheroid formation.
72:5363-5363.
2012
-
Abstract LB-327: Validation of a breast cancer risk prediction model in African American women.
72.
2012
-
Abstract LB-76: Mibefradil, a novel therapy for glioblastoma: An interlaced therapy approach.
72.
2012
-
Abstract LB-87: Methylated-mediated repression of ZNF154
in ovarian cancer is associated with poor overall survival.
72.
2012
-
The role of Syndecan 1 and 4 in breast cancer brain metastasis.
72.
2012
-
A Randomized Phase II Trial of Vitamin D vs Placebo in Premenopausal Women: CALGB 70806..
71.
2011
-
P1-01-15: Do Serum Cytokines Predict Breast Cancer Behavior?.
71.
2011
-
P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome..
71.
2011
-
P1-13-03: Zoledronic Acid Induces an Immune Response in Breast Cancer Patients through Stimulation of Central Memory and Effector Memory gamma/delta T-Cells..
71.
2011
-
P3-14-04: Assessment of Genomic Prognostic Signatures as Predictors of Response to Neoadjuvant Chemotherapy in Patients with Early Stage Breast Cancer..
71.
2011
-
Correction: Aggressive Fibromatosis (Desmoid Tumor) Is Derived from Mesenchymal Progenitor Cells.
71:6084-6084.
2011
-
Abstract 1635: Short hairpin RNA-mediated transcriptional suppression of glutathione S-transferase P1 suppresses growth and induces apoptosis through altered MAP kinase signaling in melanoma cells.
71:1635-1635.
2011
-
Abstract 2277: Loss of nuclear localized and tyrosine phosphorylated Stat5: A predictor of poor clinical outcome and increased risk of antiestrogen therapy failure in breast cancer.
71:2277-2277.
2011
-
Abstract 2337: Defining significance of the novel tGLI1 transcription factor in cancer growth and progression.
71:2337-2337.
2011
-
Abstract 2482: Bat3 facilitates histone H3 lysine 79 dimethylation by DOT1L to promote ionizing radiation-induced 53BP1 foci formation during G1- and G2-phases of the cell cycle.
71:2482-2482.
2011
-
Abstract 2754: Maternal use of antidepressants in pregnancy is associated with hypermethylation at the IGF2
imprinted control regions in the offspring in a race-dependent fashion.
71:2754-2754.
2011
-
Abstract 2767: Genetic variation in obesity-related genes ADBR2, ADBR3, GHRL, HSD11B1, and SHC1 and risk of prostate cancer: A VA case-control study.
71:2767-2767.
2011
-
Abstract 2817: An RNA aptamer is a potential biomarker for pancreatic cancer.
71:2817-2817.
2011
-
Abstract 3014: Quantitative accuracy of Illumina HumanMethylation27 Infinium BeadChip data assessed by pyrosequencing.
71:3014-3014.
2011
-
Abstract 3086: Interactions of nucleolin and ribosomal protein RPL26 in the translational control of human p53 mRNA.
71:3086-3086.
2011
-
Abstract 3311: IL6-Stat3 signaling promotes glioma stem cell (GSC) survival under hypoxia environment through inhibition of cell-death inducing gene Bnip3.
71:3311-3311.
2011
-
Abstract 4417: Characterization of xenograft-derived EGFRvIII-positive GBM cell cultures reveals functional interactions between EGFRvIII, wild-type EGFR, and p53.
71:4417-4417.
2011
-
Abstract 4602: Cholesterol and ezetimibe: Effects on tumor growth and survival outcomes: An interim analysis.
71:4602-4602.
2011
-
Abstract 4637: Intra-individual changes in circulating IGF-1 and IGF-1/IGFBP-3 molar ratio are associated with colorectal adenomatous polyps presence.
71:4637-4637.
2011
-
Abstract 4697: Metabolic regulation of caspase-2.
71:4697-4697.
2011
-
Abstract 5306: 18F-EF5 microPET imaging of treatment response from a novel, hypoxia-selective cytotoxin SN30000 in a human lung cancer xenograft model.
71:5306-5306.
2011
-
Abstract 615: PP2A activation as a strategy for treatment of breast cancer.
71:615-615.
2011
-
Abstract 703: GSTP1 inhibition of HSP27 phosphorylation contributes to glioma drug resistance.
71:703-703.
2011
-
Abstract LB-255: A mass spectrometry platform to quantitatively profile cancer cell metabolism from cells, tumors, and fixed tissue.
71.
2011
-
Abstract LB-454: Serum metabolic profiles and endometrial cancer.
71.
2011
-
Abstract P1-04-01: X-Linked Inhibitor of Apoptosis Protein (XIAP) Regulates TRAIL-Induced Apoptosis in Inflammatory Breast Cancer Cells.
70.
2010
-
Abstract P2-12-01: Is Cancer-Specific Distress Correlated with Time to Definitive Surgery in Breast Cancer Patients?.
70.
2010
-
Dosimetric Comparison of Radiotherapy for Left Sided Breast Cancer: Breath-Hold Versus Free-Breathing.
70.
2010
-
Voluntary running prevents progressive memory decline and increases adult hippocampal neurogenesis and growth factor expression after whole-brain irradiation..
70:9329-9338.
2010
-
Abstract 3971: The type III tgf-β receptor mediates bmp signaling in normal and cancerous mammary epithelial cells.
70:3971-3971.
2010
-
Abstract 4831: ATM signals to TSC2 in the cytoplasm to regulate mTORC1 and autophagy in response to ROS.
70:4831-4831.
2010
-
Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1.
70:5061-5061.
2010
-
Abstract 5338: Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T cell killing mediated by CEA/CD3-bispecific T cell-engaging BiTE antibody.
70:5338-5338.
2010
-
Abstract LB-213: Plasma soluble VEGFR1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.
70.
2010
-
Correction: Transforming growth factor α expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines (Cancer Research (2006) 66, 7, (3802-3812)).
70:852-853.
2010
-
Diagnostic and Therapeutic Applications of Nanotechnology..
69:484S-484S.
2009
-
Melanoma proliferation and chemoresistance controlled by the DEK oncogene..
69:6405-6413.
2009
-
Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway..
69:4621-4628.
2009
-
Association between serous invasive ovarian cancer and variants in candidate DNA damage response genes.
69.
2009
-
CTCF binding at a novel intragenic binding site is associated with elevated IGF2 expression in serous epithelial ovarian cancer.
69.
2009
-
Differential roles of DR4, DR5 and c-FLIP in regulation of geranylgeranyltransferase I inhibitor-induced augmentation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
69.
2009
-
EGFR and EGFRvIII attenuate drug-induced apoptosis in glioblastomas via mitochondrial transport and interaction with pro-apoptotic proteins:A novel EGFR/EGFRvIII-mediated mechanism in drug resistance.
69.
2009
-
Hyperthermia-induced HIF-1 activation and tumor reoxygenation.
69.
2009
-
In vitro characterization of the antitumor effects of dasatinib (BMS-354825) in combination with paclitaxel and carboplatin in human ovarian cancer cell lines.
69.
2009
-
Phosphorylation of a C-terminal tyrosine of GSTP1 by EGFR dissociates GSTP1 from the GSTP1-JNK complex leading to JNK activation in glioblastoma cells.
69.
2009
-
Prostate derived Ets factor (PDEF), an emerging biomarker in cancer.
69.
2009
-
Serine-phosphorylation of the GSTP1 protein by PKC\#945; increase GSTP1-mediated cisplatin metabolism and descrease cisplatin-induced DNA interstrand cross link formation and cisplatin sensitivity in human glioma cells.
69.
2009
-
Structural and functional analysis of Nucleophosmin I (NPM1) in human malignant gliomas.
69.
2009
-
UCN-01 is effective in targeting ovarian cancer spheroids.
69.
2009
-
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines.
69:3356-3363.
2009
-
Genome-Wide Impact of Androgen Receptor Trapped clone-27 Loss on Androgen-Regulated Transcription in Prostate Cancer Cells.
69:3140-3147.
2009
-
Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis..
69:1199-1204.
2009
-
Intraoperative optical breast tissue characterization device for tumor margin assessment.
69:101S-101S.
2009
-
Podoplanin is a novel antibody-based therapeutic target for glioblastoma.
69.
2009
-
IFN-β signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors (Cancer Research (August 1, 2007) 67 (7124-7131)).
68:956.
2008
-
Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis..
67:9713-9720.
2007
-
Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus..
67:10038-10046.
2007
-
Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators..
67:9549-9560.
2007
-
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression..
67:9066-9076.
2007
-
5-Azacytidine induced methyltransferase-DNA adducts block DNA replication in vivo..
67:8248-8254.
2007
-
Side population cells isolated from mesenchymal neoplasms have tumor initiating potential..
67:8216-8222.
2007
-
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy..
67:7893-7900.
2007
-
IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors..
67:7124-7131.
2007
-
The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescence..
67:6691-6699.
2007
-
In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck..
67:5628-5634.
2007
-
Loss of betaglycan expression in ovarian cancer: role in motility and invasion..
67:5231-5238.
2007
-
Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase..
67:4716-4724.
2007
-
Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer..
67:5003-5008.
2007
-
Meeting report: Translational Research at the Aging and Cancer Interface..
67:4560-4563.
2007
-
Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression..
67:4783-4789.
2007
-
Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors..
67:4418-4424.
2007
-
Thrombin-cleaved COOH(-) terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells..
67:4088-4097.
2007
-
Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth..
67:3835-3844.
2007
-
Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia..
67:3827-3834.
2007
-
Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation..
67:2990-3001.
2007
-
Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells..
67:3286-3294.
2007
-
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer..
67:3027-3035.
2007
-
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice..
67:2414-2419.
2007
-
Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1..
67:1461-1471.
2007
-
Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting..
67:854-855.
2007
-
The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer..
67:1090-1098.
2007
-
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity..
67:371-380.
2007
-
Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation..
66:11565-11570.
2006
-
I2 imaging: cancer biology and the tumor microenvironment..
66:11097-11099.
2006
-
Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum..
66:11424-11431.
2006
-
A role for mitochondrial dysfunction in perpetuating radiation-induced genomic instability..
66:10377-10383.
2006
-
Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB..
66:10553-10559.
2006
-
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk..
66:10302-10307.
2006
-
Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer..
66:7653-7660.
2006
-
A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy..
66:3987-3991.
2006
-
Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression..
66:4065-4078.
2006
-
Abnormal gene expression profiles in unaffected parents of patients with hereditary-type retinoblastoma..
66:3428-3433.
2006
-
Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells..
66:3773-3781.
2006
-
Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines..
66:3802-3812.
2006
-
Common cancer biomarkers..
66:2953-2961.
2006
-
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma..
66:3294-3302.
2006
-
Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor..
66:3162-3168.
2006
-
Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival..
66:3323-3330.
2006
-
N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma..
66:2666-2672.
2006
-
Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor..
66:2219-2223.
2006
-
Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells..
66:2210-2218.
2006
-
Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection..
66:1792-1798.
2006
-
Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase..
66:875-882.
2006
-
Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer..
66:1025-1032.
2006
-
Topological and functional discovery in a gene coexpression meta-network of gastric cancer.
66:232-241.
2006
-
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells..
65:11510-11519.
2005
-
Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis..
65:11658-11666.
2005
-
Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy..
65:11762-11770.
2005
-
Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity..
65:11276-11281.
2005
-
Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve..
65:11044-11050.
2005
-
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts..
65:11156-11163.
2005
-
Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model..
65:10371-10380.
2005
-
A network of genetic events sufficient to convert normal human cells to a tumorigenic state..
65:9824-9828.
2005
-
Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway..
65:9807-9816.
2005
-
Enhancement of cancer radiation therapy by use of adenovirus-mediated secretable glucose-regulated protein 94/gp96 expression..
65:9126-9131.
2005
-
Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells..
65:9164-9168.
2005
-
Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma..
65:8869-8877.
2005
-
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer..
65:9064-9072.
2005
-
Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo..
65:8853-8860.
2005
-
Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy..
65:8423-8432.
2005
-
A novel method for viral gene delivery in solid tumors..
65:7541-7545.
2005
-
Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report..
65:7041-7044.
2005
-
Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes..
65:7137-7144.
2005
-
Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation..
65:5498-5505.
2005
-
Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling..
65:5031-5037.
2005
-
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors..
65:5054-5062.
2005
-
Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat..
65:5163-5171.
2005
-
Genetic modeling of human rhabdomyosarcoma..
65:4490-4495.
2005
-
Gene expression profiling and genetic markers in glioblastoma survival..
65:4051-4058.
2005
-
Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model..
65:3716-3725.
2005
-
The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase..
65:3883-3893.
2005
-
p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase..
65:3745-3750.
2005
-
Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci..
65:2653-2661.
2005
-
Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death..
65:2070-2075.
2005
-
A mechanism-based antioxidant approach for the reduction of skin carcinogenesis..
65:1401-1405.
2005
-
Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity..
65:1369-1375.
2005
-
Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid..
65:919-924.
2005
-
Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer..
65:722-726.
2005
-
The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer..
65:18-25.
2005
-
Wavelet transformations of tumor expression profiles reveals a pervasive genome-wide imprinting of aneuploidy on the cancer transcriptome.
65:186-194.
2005
-
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry..
64:9018-9026.
2004
-
The human glutathione S-transferase P1 protein is phosphorylated and its metabolic function enhanced by the Ser/Thr protein kinases, cAMP-dependent protein kinase and protein kinase C, in glioblastoma cells..
64:9131-9138.
2004
-
Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin..
64:8381-8388.
2004
-
Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha..
64:8139-8142.
2004
-
Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer..
64:7279-7287.
2004
-
p73 G4C14-to-A4T14 polymorphism and risk of lung cancer..
64:6863-6866.
2004
-
Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing..
64:6010-6017.
2004
-
Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors..
64:5664-5671.
2004
-
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis..
64:5795-5803.
2004
-
Polymorphisms of DNA repair genes and risk of glioma..
64:5560-5563.
2004
-
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer..
64:5882-5890.
2004
-
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas..
64:5048-5050.
2004
-
Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts..
64:4601-4610.
2004
-
Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma..
64:4378-4384.
2004
-
Disappearance of the telomere dysfunction-induced stress response in fully senescent cells..
64:3748-3752.
2004
-
Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility..
64:3550-3558.
2004
-
Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis..
64:3679-3686.
2004
-
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancer..
64:3566-3571.
2004
-
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers..
64:3014-3021.
2004
-
Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues..
64:2782-2792.
2004
-
GW112, a novel antiapoptotic protein that promotes tumor growth..
64:2474-2481.
2004
-
Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity..
64:2030-2038.
2004
-
Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells..
64:2175-2182.
2004
-
A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease..
64:1220-1223.
2004
-
Protein kinase C zeta transactivates hypoxia-inducible factor alpha by promoting its association with p300 in renal cancer..
64:456-462.
2004
-
Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo..
64:446-451.
2004
-
Transcriptional activation of p21(waf1/cip1) by alkylphospholipids: role of the mitogen-activated protein kinase pathway in the transactivation of the human p21(waf1/cip1) promoter by Sp1..
64:743-750.
2004
-
Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells..
63:8451-8460.
2003
-
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells..
63:8345-8350.
2003
-
Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion..
63:8029-8036.
2003
-
Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease..
63:7051-7055.
2003
-
Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis..
63:7167-7175.
2003
-
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity..
63:7483-7489.
2003
-
CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin..
63:6751-6757.
2003
-
Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobin..
63:6162-6165.
2003
-
Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin..
63:5716-5722.
2003
-
Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenation..
63:4705-4712.
2003
-
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression..
63:4299-4304.
2003
-
Distinct gene expression phenotypes of cells lacking Rb and Rb family members..
63:3716-3723.
2003
-
Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men..
63:3486-3489.
2003
-
In situ detection of neoplastic transformation and chemopreventive effects in rat esophagus epithelium using angle-resolved low-coherence interferometry..
63:3556-3559.
2003
-
Bradykinin receptor subtype 1 expression and function in prostate cancer..
63:2037-2041.
2003
-
Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells..
63:2127-2133.
2003
-
Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing..
63:2316-2321.
2003
-
Characterization of sporadic colon cancer by patterns of genomic instability..
63:1608-1614.
2003
-
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer..
63:1652-1656.
2003
-
Genetic susceptibility to benzene-induced toxicity: role of NADPH: quinone oxidoreductase-1..
63:929-935.
2003
-
Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance..
63:780-786.
2003
-
Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer..
63:6-11.
2003
-
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells..
62:7328-7334.
2002
-
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis..
62:7357-7363.
2002
-
HEPSIN inhibits cell growth/invasion in prostate cancer cells..
62:6812-6816.
2002
-
Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha..
62:6357-6361.
2002
-
Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells..
62:6039-6044.
2002
-
Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints..
62:6070-6079.
2002
-
Tirapazamine: a hypoxia-activated topoisomerase II poison..
62:5248-5253.
2002
-
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer..
62:4992-4995.
2002
-
Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation..
62:4588-4591.
2002
-
Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance..
62:4464-4468.
2002
-
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness..
62:3581-3586.
2002
-
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion..
62:3335-3339.
2002
-
Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis..
62:3395-3401.
2002
-
Prevalence and spectrum of p53 mutations associated with smoking in breast cancer..
62:1987-1995.
2002
-
Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status..
62:781-788.
2002
-
The CLN3 gene is a novel molecular target for cancer drug discovery..
62:801-808.
2002
-
Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer..
61:8712-8717.
2001
-
Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer..
61:8651-8653.
2001
-
Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study..
61:8465-8469.
2001
-
Urea as a recovery marker for quantitative assessment of tumor interstitial solutes with microdialysis..
61:7964-7970.
2001
-
The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein..
61:7525-7529.
2001
-
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study..
61:7233-7239.
2001
-
Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition..
61:7163-7170.
2001
-
Molecular classification of human carcinomas by use of gene expression signatures..
61:7388-7393.
2001
-
ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors..
61:6931-6937.
2001
-
Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability..
61:6413-6422.
2001
-
A SAGE (serial analysis of gene expression) view of breast tumor progression..
61:5697-5702.
2001
-
Inhibition of DNA replication by tirapazamine..
61:5425-5431.
2001
-
Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?.
61:5016-5023.
2001
-
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2..
61:4892-4900.
2001
-
Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation..
61:3986-3997.
2001
-
Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma..
61:4143-4154.
2001
-
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer..
61:3581-3585.
2001
-
A genetically tractable model of human glioma formation..
61:3556-3560.
2001
-
An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study..
61:3321-3325.
2001
-
Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation..
61:3281-3284.
2001
-
Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population..
61:3272-3275.
2001
-
Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature..
61:3027-3032.
2001
-
Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor..
61:2917-2922.
2001
-
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation..
61:2782-2787.
2001
-
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study..
61:2533-2536.
2001
-
Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta..
61:2328-2334.
2001
-
Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients..
61:1354-1357.
2001
-
Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis..
61:1445-1450.
2001
-
Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia..
61:1548-1554.
2001
-
Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer..
61:1233-1240.
2001
-
Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures..
61:428-432.
2001
-
Aberrant promoter methylation of multiple genes in non-small cell lung cancers..
61:249-255.
2001
-
Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma..
61:71-75.
2001
-
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer..
61:110-117.
2001
-
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release..
60:6950-6957.
2000
-
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer..
60:6859-6863.
2000
-
Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion..
60:6851-6855.
2000
-
PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer..
60:6568-6572.
2000
-
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer..
60:5382-5385.
2000
-
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size..
60:4440-4445.
2000
-
Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases..
60:4629-4637.
2000
-
Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody..
60:4453-4460.
2000
-
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells..
60:3904-3908.
2000
-
Heat-induced gene expression as a novel targeted cancer gene therapy strategy..
60:3435-3439.
2000
-
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma..
60:2926-2935.
2000
-
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice..
60:2218-2224.
2000
-
Oncogenic base substitution mutations in circulating leukocytes of normal individuals..
60:1830-1834.
2000
-
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model..
60:1197-1201.
2000
-
Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells..
60:1028-1034.
2000
-
Protein phosphorylation is a regulatory mechanism for O6-alkylguanine-DNA alkyltransferase in human brain tumor cells..
60:282-287.
2000
-
Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18..
59:6205-6213.
1999
-
Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland..
59:5815-5821.
1999
-
Loss of KAI1 expression in the progression of colorectal cancer..
59:5724-5731.
1999
-
A public database for gene expression in human cancers..
59:5403-5407.
1999
-
Abnormal Fhit expression in malignant and premalignant lesions of the cervix..
59:5270-5274.
1999
-
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers..
59:4314-4319.
1999
-
Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery..
59:4136-4141.
1999
-
Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor..
59:4129-4135.
1999
-
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma..
59:3064-3067.
1999
-
Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555)..
59:2395-2401.
1999
-
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238..
59:1947-1953.
1999
-
Migration of human dendritic cells after injection in patients with metastatic malignancies..
59:56-58.
1999
-
Loss of atm radiosensitizes multiple p53 null tissues..
58:5637-5639.
1998
-
Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants..
58:4940-4946.
1998
-
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression..
58:4740-4744.
1998
-
The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction..
58:3603-3610.
1998
-
Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells..
58:2965-2968.
1998
-
Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-kappaB activation in drug resistance..
58:3059-3065.
1998
-
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis..
58:2793-2800.
1998
-
Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias..
58:2500-2503.
1998
-
Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors..
58:1387-1390.
1998
-
Mutations of the bacteriophage T4 type II DNA topoisomerase that alter sensitivity to antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide and an antibacterial quinolone..
58:1260-1267.
1998
-
Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model..
58:302-309.
1998
-
DNA adducts in human pancreatic tissues and their potential role in carcinogenesis..
58:38-41.
1998
-
Met and hepatocyte growth factor/scatter factor expression in human gliomas..
57:5391-5398.
1997
-
Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA..
57:5426-5433.
1997
-
Androgen-independent prostate cancer progression in the TRAMP model..
57:4687-4691.
1997
-
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multi forme xenograft (vol 57, pg 2933, 1997).
57:4973-4973.
1997
-
PTEN/MMAC1 mutations in endometrial cancers..
57:4736-4738.
1997
-
p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene..
57:4474-4477.
1997
-
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro..
57:4309-4315.
1997
-
PTEN gene mutations are seen in high-grade but not in low-grade gliomas..
57:4187-4190.
1997
-
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII..
57:4130-4140.
1997
-
Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells..
57:3929-3934.
1997
-
Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p..
57:3653-3656.
1997
-
Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model..
57:3325-3330.
1997
-
Dissociation of radiation-induced phosphorylation of replication protein A from the S-phase checkpoint..
57:3386-3389.
1997
-
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas..
57:3126-3130.
1997
-
CaN19 expression in benign and malignant hyperplasias of the skin and oral mucosa: evidence for a role in regenerative differentiation..
57:3055-3062.
1997
-
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft..
57:2933-2936.
1997
-
Metal ion-dependent hydrogen peroxide-induced DNA damage is more sequence specific than metal specific..
57:2394-2403.
1997
-
FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations..
57:2256-2267.
1997
-
Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas..
57:1673-1677.
1997
-
Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells..
57:1561-1568.
1997
-
Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate..
57:1510-1515.
1997
-
Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk..
57:1194-1198.
1997
-
Erratum: (Cancer Research (July 15, 1997) (2933-2936)).
57:4973.
1997
-
Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma..
56:5522-5528.
1996
-
Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas..
56:5347-5350.
1996
-
Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family..
56:5063-5070.
1996
-
High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2..
56:5044-5046.
1996
-
Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate..
56:4970-4977.
1996
-
Cell cycle control of BRCA2..
56:4590-4594.
1996
-
Identification and characterization of proximal 6q deletions in prostate cancer..
56:4150-4153.
1996
-
Metastatic prostate cancer in a transgenic mouse..
56:4096-4102.
1996
-
Reduced DNA repair capacity in lung cancer patients..
56:4103-4107.
1996
-
Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer..
56:3975-3979.
1996
-
In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer..
56:3638-3641.
1996
-
Separate pathways for p53 induction by ionizing radiation and N-(phosphonoacetyl)-L-aspartate..
56:3659-3662.
1996
-
Rb and p16INK4a expression in resected non-small cell lung tumors..
56:3415-3420.
1996
-
Human colorectal carcinomas specifically accumulate Mr 42,000 ubiquitin-conjugated cytokeratin 8 fragments..
56:2752-2757.
1996
-
Distal nephron renal tumors: microsatellite allelotype..
56:1892-1895.
1996
-
Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand..
56:1695-1701.
1996
-
Mutagen sensitivity and risk of gliomas: a case-control analysis..
56:1484-1486.
1996
-
5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation..
56:1204-1209.
1996
-
Particle-emitting endoradiotherapeutic agent undergoing DNA incorporation.
56:1204-1209.
1996
-
Distinct regions of allelic loss on 13q in prostate cancer..
56:1142-1145.
1996
-
Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein..
56:1063-1067.
1996
-
Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma..
56:941-943.
1996
-
5-[At-211]astato-2'-deoxyuridine, an alpha-particle-emitting endoradiotherapeutic agent undergoing DNA incorporation.
56:1204-1209.
1996
-
MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation..
56:16-20.
1996
-
Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression..
55:6006-6011.
1995
-
Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity..
55:5664-5669.
1995
-
Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods..
55:5842s-5846s.
1995
-
Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma..
55:5396-5399.
1995
-
Simultaneous amplification of four DNA repair genes and beta-actin in human lymphocytes by multiplex reverse transcriptase-PCR..
55:5025-5029.
1995
-
Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells..
55:4646-4650.
1995
-
Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts..
55:4375-4382.
1995
-
Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts..
55:4120-4126.
1995
-
Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats..
55:3803-3809.
1995
-
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size..
55:3752-3756.
1995
-
Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II..
55:3634-3639.
1995
-
Novel suppressor loci on chromosome 14q in primary bladder cancer..
55:3246-3249.
1995
-
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas..
55:3140-3148.
1995
-
Activity of temozolomide in the treatment of central nervous system tumor xenografts..
55:2853-2857.
1995
-
Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay..
55:2876-2882.
1995
-
Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer..
55:2366-2372.
1995
-
Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved..
55:2284-2292.
1995
-
Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells..
55:1842-1846.
1995
-
Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels..
55:1039-1044.
1995
-
Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein..
55:1168-1175.
1995
-
Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta..
55:944-948.
1995
-
Autocrine growth stimulation by transforming growth factor alpha in asbestos-transformed rat mesothelial cells..
55:530-536.
1995
-
NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells..
55:330-335.
1995
-
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression..
55:51-56.
1995
-
Deletion of p16 and p15 genes in brain tumors..
54:6353-6358.
1994
-
Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells..
54:5414-5419.
1994
-
Cell cycle studies of cyclocreatine, a new anticancer agent..
54:5160-5165.
1994
-
Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase..
54:5123-5130.
1994
-
The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia..
54:5054-5058.
1994
-
Intrathecal melphalan therapy of human neoplastic meningitis in athymic nude rats..
54:4710-4714.
1994
-
Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate..
54:4719-4725.
1994
-
Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows..
54:4564-4568.
1994
-
Allelotype of endometrial carcinoma..
54:4294-4298.
1994
-
Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium..
54:3696-3699.
1994
-
Determination of local oxygen consumption rates in tumors..
54:3333-3336.
1994
-
Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan..
54:3487-3493.
1994
-
HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer..
54:3387-3390.
1994
-
Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft..
54:3352-3356.
1994
-
Wilms' tumor suppressor gene expression in rat and human mesothelioma..
54:3101-3106.
1994
-
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers..
54:2861-2864.
1994
-
The p53-dependent gamma-ray response of GADD45..
54:2755-2760.
1994
-
Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene..
54:1678-1683.
1994
-
Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line..
54:1791-1794.
1994
-
Alterations of the TP53 gene in human gliomas..
54:1324-1330.
1994
-
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis..
54:1169-1174.
1994
-
Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model..
54:475-481.
1994
-
DNA repair related to multiple skin cancers and drug use..
54:437-440.
1994
-
Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy..
54:539-546.
1994
-
Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele..
54:25-27.
1994
-
Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells..
53:5663-5668.
1993
-
Genetic instability of microsatellites in endometrial carcinoma..
53:5100-5103.
1993
-
Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage..
53:4164-4168.
1993
-
Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody..
53:4143-4147.
1993
-
Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue..
53:3765-3770.
1993
-
Hepatic cellular distribution of cytochrome P-450 IA1 in rainbow trout (Oncorhynchus mykiss): an immunohisto- and cytochemical study..
53:3700-3706.
1993
-
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas..
53:3217-3220.
1993
-
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors..
53:3172-3178.
1993
-
Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide..
53:2338-2343.
1993
-
Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain..
53:1998-2004.
1993
-
Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma..
53:1906-1910.
1993
-
Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression..
53:1939-1944.
1993
-
Chromatophoromas and chromatophore hyperplasia in Pacific rockfish (Sebastes spp.)..
53:1761-1769.
1993
-
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus..
53:1218-1221.
1993
-
Modification of DNA bases in chromatin of intact target human cells by activated human polymorphonuclear leukocytes..
53:1269-1272.
1993
-
Intraarterial Therapy of Human Glioma Xenografts in Athymic Rats Using 4-Hydroperoxycyclophosphamide.
53:2338-2343.
1993
-
Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo..
53:120-126.
1993
-
Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice..
52:6553-6560.
1992
-
The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma..
52:5590-5596.
1992
-
Cyclophosphamide resistance in medulloblastoma..
52:5373-5378.
1992
-
Pharmacokinetic analysis of the perivascular distribution of bifunctional antibodies and haptens: comparison with experimental data..
52:5838-5844.
1992
-
Localization of fluorine-18-labeled Mel-14 monoclonal antibody F(ab')2 fragment in a subcutaneous xenograft model..
52:5054-5060.
1992
-
Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra..
52:5018-5023.
1992
-
Diminished leukocyte-endothelium interaction in tumor microvessels..
52:4265-4268.
1992
-
Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines..
52:3908-3913.
1992
-
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma..
52:3871-3874.
1992
-
Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms..
52:2624-2627.
1992
-
Induction and spontaneous regression of intense pulmonary neuroendocrine cell differentiation in a model of preneoplastic lung injury..
52:2677s-2686s.
1992
-
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial..
52:2456-2459.
1992
-
Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo..
52:2180-2185.
1992
-
Overexpression and mutation of p53 in endometrial carcinoma..
52:1622-1627.
1992
-
Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines..
52:1144-1148.
1992
-
Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestos-induced rat mesothelioma..
52:301-306.
1992
-
Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells..
52:394-399.
1992
-
Induction and spontaneous regression of intense pulmonary neuroendocrine cell differentiation in a model of preneoplastic lung injury.
52.
1992
-
Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.
52:483-486.
1992
-
Participation of p53 protein in the cellular response to DNA damage..
51:6304-6311.
1991
-
Human colonic sulfomucin identified by a specific monoclonal antibody..
51:5728-5735.
1991
-
Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line..
51:4643-4648.
1991
-
Infrequent p53 gene mutations in medulloblastomas..
51:4721-4723.
1991
-
Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6..
51:4415-4422.
1991
-
Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate..
51:4164-4169.
1991
-
Levels of p53 protein increase with maturation in human hematopoietic cells..
51:4279-4286.
1991
-
DNA sequence specificity of doxorubicin-induced mutational damage in uvrB- Escherichia coli..
51:3930-3937.
1991
-
Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MR..
51:3906-3909.
1991
-
Trisomy of rat chromosome 1 associated with mesothelial cell transformation..
51:4059-4066.
1991
-
Production and characterization of antipeptide antibodies against human O6-methylguanine-DNA methyltransferase..
51:3339-3344.
1991
-
Topoisomerase II levels during granulocytic maturation in vitro and in vivo..
51:3534-3543.
1991
-
Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma..
51:2973-2978.
1991
-
Overexpression and mutation of p53 in epithelial ovarian cancer..
51:2979-2984.
1991
-
Pharmacokinetic analysis of two-step approaches using bifunctional and enzyme-conjugated antibodies..
51:3119-3130.
1991
-
Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast cancer..
51:3037-3043.
1991
-
Maintenance of p53 alterations throughout breast cancer progression..
51:2605-2610.
1991
-
Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression..
51:1202-1209.
1991
-
Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin..
51:789-793.
1991
-
Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages..
51:387-393.
1991
-
Participation of p53 Protein in the Cellular Response to DNA Damage.
51:6304-6311.
1991
-
Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
51:105-109.
1991
-
Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts..
50:8017-8022.
1990
-
Radiolocalization of human pancreatic tumors in athymic mice by monoclonal antibody DU-PAN 1..
50:7246-7251.
1990
-
Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines..
50:6976-6980.
1990
-
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia..
50:6823-6826.
1990
-
Increased erbB-2 gene copies and expression in multiple stages of breast cancer..
50:6701-6707.
1990
-
Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro..
50:6039-6044.
1990
-
Cytotoxicity phase of diethylnitrosamine-induced hepatic neoplasia in medaka..
50:5504-5514.
1990
-
Synergistic cytotoxicity using 2'-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cells..
50:4572-4577.
1990
-
Effect of thimerosal in leukemia, in leukemic cell lines, and on normal hematopoiesis..
50:4429-4435.
1990
-
Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration..
50:4105-4110.
1990
-
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer..
50:4087-4091.
1990
-
Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment..
50:3514-3520.
1990
-
Evaluation of arylmethylaminopropanediols by a novel in vitro pharmacodynamic assay: correlation with antitumor activity in vivo..
50:3663-3669.
1990
-
Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein production by human colon carcinoma cells..
50:3331-3338.
1990
-
Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cells..
50:3231-3238.
1990
-
Wilms' tumor and paternal occupation..
50:3212-3217.
1990
-
Differential expression of ros oncogene in primary human astrocytomas and astrocytoma cell lines..
50:3032-3035.
1990
-
Oncogene amplification in pediatric brain tumors..
50:2987-2990.
1990
-
Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts..
50:2347-2350.
1990
-
Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity..
50:2455-2462.
1990
-
Nonuniform alteration of cis-diamminedichloroplatinum(II) tissue distribution in dogs with whole body hyperthermia..
50:2075-2080.
1990
-
Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis..
50:1954-1959.
1990
-
Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia..
50:1803-1809.
1990
-
Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14..
50:1822-1827.
1990
-
Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells..
50:1397-1402.
1990
-
Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas..
50:1251-1256.
1990
-
Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas..
50:492-498.
1990
-
Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft..
50:284-287.
1990
-
Immunoaffinity purification of human O6-alkylguanine-DNA alkyltransferase using newly developed monoclonal antibodies..
50:58-61.
1990
-
ESTABLISHMENT OF A MELPHALAN-RESISTANT RHABDOMYOSARCOMA XENOGRAFT WITH CROSS-RESISTANCE TO VINCRISTINE AND ENHANCED SENSITIVITY FOLLOWING BUTHIONINE SULFOXIMINE-MEDIATED GLUTATHIONE DEPLETION.
49:6917-6922.
1989
-
Establishment of a Melphalan-Resistant Rhabdomyosarcoma Xenograft with Cross-Resistance to Vincristine and Enhanced Sensitivity Following Buthionine Sulfoximine-Mediated Glutathione Depletion.
49:6917-6922.
1989
-
Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion..
49:6917-6922.
1989
-
Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma..
49:6883-6888.
1989
-
5 NEW EPITOPE-DEFINED MONOCLONAL-ANTIBODIES REACTIVE WITH GM2 AND HUMAN GLIOMA AND MEDULLOBLASTOMA CELL-LINES.
49:6645-6651.
1989
-
Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines..
49:6645-6651.
1989
-
In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator..
49:6615-6620.
1989
-
Decreased DNA interstrand cross-linking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione..
49:5954-5958.
1989
-
Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine showing correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels..
49:5761-5765.
1989
-
Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate..
49:5543-5549.
1989
-
Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione..
49:5258-5261.
1989
-
Reduction of difluoromethylornithine-induced thrombocytopenia in rats with ornithine while maintaining antitumor activity..
49:4159-4162.
1989
-
Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer..
49:4057-4061.
1989
-
Modulation of the transformed and neoplastic phenotype of rat fibroblasts by MHC-I gene expression..
49:3392-3395.
1989
-
Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancer..
49:3070-3080.
1989
-
Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies..
49:2807-2813.
1989
-
Differential modulation of gene induction by glucocorticoids and antiglucocorticoids in rat hepatoma tissue culture cells..
49:2244s-2252s.
1989
-
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential..
49:2091-2095.
1989
-
Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods..
49:1052-1056.
1989
-
Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases..
49:887-894.
1989
-
Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H/10T1/2 clone 8 mouse embryo cells..
49:1038-1044.
1989
-
Lack of correlation between induction of chemotactic peptide receptors and stimulus-induced actin polymerization in HL-60 cells treated with dibutyryl cyclic adenosine monophosphate or retinoic acid..
48:6721-6726.
1988
-
Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts..
48:5701-5707.
1988
-
Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function..
48:5604-5609.
1988
-
Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma..
48:5397-5402.
1988
-
Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents..
48:4189-4195.
1988
-
The relationship of modulation of major histocompatibility complex class I antigens to retrovirus transformation in rat cell lines..
48:3816-3821.
1988
-
Restriction of tumor growth in mice by sodium-deficient diet..
48:3445-3448.
1988
-
Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice..
48:2764-2767.
1988
-
Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6..
48:2904-2910.
1988
-
Differential expression of a sialoglycoprotein with an approximate molecular weight of 900,000 on metastatic human colon carcinoma cells growing in culture and in tumor tissues..
48:2353-2360.
1988
-
Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts..
48:2231-2238.
1988
-
Clearance and distribution of recombinant murine gamma-interferon in mice..
48:2021-2024.
1988
-
Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate..
48:1446-1450.
1988
-
Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer..
48:1663-1670.
1988
-
Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody..
48:1286-1294.
1988
-
Optimization and characterization of the capillary human tumor clonogenic cell assay..
48:715-724.
1988
-
Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model..
48:559-566.
1988
-
Specific chromosomal abnormalities in malignant human gliomas..
48:405-411.
1988
-
Unexpected toxicity associated with use of body surface area for dosing melphalan in the dog..
48:288-290.
1988
-
Therapeutic Efficacy of Antiglioma Mesenchymal Extracellular Matrix 131I-Radiolabeled Murine Monoclonal Antibody in a Human Glioma Xenograft Model.
48:584-588.
1988
-
Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors..
47:6402-6406.
1987
-
Effects of gamma-interferon on the endocrine system: results from a phase I study..
47:6397-6401.
1987
-
Increased expression of the glucose-regulated gene encoding the Mr 78,000 glucose-regulated protein in chemically and radiation-transformed C3H 10T1/2 mouse embryo cells..
47:6220-6224.
1987
-
Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene..
47:5861-5867.
1987
-
Bioavailability of estradiol as a marker for breast cancer risk assessment..
47:5224-5229.
1987
-
Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement..
47:4608-4612.
1987
-
Regional localization of a glioma-associated antigen defined by monoclonal antibody 81C6 in vivo: kinetics and implications for diagnosis and therapy..
47:4432-4443.
1987
-
Expression of major histocompatibility complex class I antigens in normal and transformed rat thyroid epithelial cell lines..
47:4178-4183.
1987
-
Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay..
47:3718-3724.
1987
-
Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks..
47:3303-3308.
1987
-
Progressive formation of DNA lesions in cultured Ehrlich ascites tumor cells treated with hydroxyurea..
47:2755-2758.
1987
-
Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases..
47:2741-2747.
1987
-
Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs..
47:2334-2339.
1987
-
Comparison of monoclonal antibody delivery to intracranial glioma xenografts by intravenous and intracarotid administration..
47:1941-1946.
1987
-
Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma..
47:1836-1840.
1987
-
Simultaneous measurements of blood flow and blood-to-tissue transport in xenotransplanted medulloblastomas..
47:1687-1690.
1987
-
Ulex europeus agglutinin I-reactive high molecular weight glycoproteins of adenocarcinoma of distal colon and rectum and their possible relationship with metastatic potential..
47:881-889.
1987
-
Bioavailability of Estradiol as a Marker for Breast Cancer Risk Assessment.
47:5092-5140.
1987
-
TEMPERATURE-MEASUREMENTS IN NORMAL AND TUMOR-TISSUE OF DOGS UNDERGOING WHOLE-BODY HYPERTHERMIA.
46:6229-6235.
1986
-
Temperature measurements in normal and tumor tissue of dogs undergoing whole body hyperthermia..
46:6229-6235.
1986
-
Determination of continuous atracurium infusion rate in dogs undergoing whole-body hyperthermia..
46:5599-5601.
1986
-
Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline..
46:5969-5972.
1986
-
Production and characterization of two human glioma xenograft-localizing monoclonal antibodies..
46:5933-5940.
1986
-
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
46.
1986
-
USE OF A MONOCLONAL ANTIESTROGEN RECEPTOR ANTIBODY IN THE IMMUNOHISTOCHEMICAL EVALUATION OF HUMAN-TUMORS.
46:4244-4248.
1986
-
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors..
46:4244s-4248s.
1986
-
Relationship of erythrocyte polyamine levels and growth rate of transplantable tumors in rats..
46:3464-3468.
1986
-
Experimental chemotherapy of human medulloblastoma with classical alkylators..
46:2827-2833.
1986
-
Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer..
46:3157-3163.
1986
-
Heterogeneity in the hormonal responsiveness of clones derived from the 13762NF rat mammary tumor..
46:1920-1927.
1986
-
Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice..
46:224-228.
1986
-
Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
46:5302-5311.
1986
-
Heterogeneity in the hormonal responsiveness of clones derived from the 13762nf rat mammary tumor.
46:1920-1927.
1986
-
Temperature Measurements in Normal and Tumor Tissue of Dogs Undergoing Whole Body Hyperthermia.
46:6229-6235.
1986
-
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
45.
1985
-
Prospects for treatment of human retrovirus-associated diseases.
45.
1985
-
Comparison of Intravenous versus Intracarotid Therapy with 1,3-Bis(2-chloroethyi)-1-nitrosourea in a Rat Brain Tumor Model.
45:5240-5245.
1985
-
Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model..
45:5240-5245.
1985
-
Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool..
45:5257-5262.
1985
-
Preferential DNA-protein cross-linking by NiCl2 in magnesium-insoluble regions of fractionated Chinese hamster ovary cell chromatin..
45:5787-5794.
1985
-
Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas..
45:4185-4191.
1985
-
Combination chemotherapy in vitro exploiting glutamine metabolism of human glioma and medulloblastoma..
45:4082-4086.
1985
-
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III)..
45:4694s-4699s.
1985
-
Influence of glutamine on the growth of human glioma and medulloblastoma in culture..
45:4077-4081.
1985
-
Prospects for treatment of human retrovirus-associated diseases..
45:4700s-4705s.
1985
-
Effect of 5-hydroxytryptamine on tissue blood flow and microwave heating of rat tumors..
45:3203-3208.
1985
-
Potential antiglioma activity of 9-hydroxy-2-N-methylellipticine as determined by pharmacological and human tumor clonogenic cell studies..
45:2988-2992.
1985
-
Growth kinetics of human colorectal carcinoma..
45:2128-2131.
1985
-
Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia..
45:1579-1586.
1985
-
COMPARISON OF INTRAVENOUS VERSUS INTRACAROTID THERAPY WITH 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA IN A RAT-BRAIN TUMOR-MODEL.
45:5240-5245.
1985
-
INVITRO VERSUS INVIVO CORRELATIONS OF CHEMOSENSITIVITY OF HUMAN MEDULLOBLASTOMA - REPLY.
45:6538-6538.
1985
-
Receptor-mediated endocytosis of carcinoembryonic antigen by rat liver Kupffer cells..
45:392-397.
1985
-
Comparison of in Vitro and in Vivo Differentiation of Myeloblastic Leukemia of the RFM/Un Mouse.
44:5594-5598.
1984
-
Comparison of in vitro and in vivo differentiation of myeloblastic leukemia of the RFM/Un mouse..
44:5594-5598.
1984
-
Comparison of in vitro and in vivo differentiation of myeloblastic leukemia of the RFM/Un mouse..
44:5594-5598.
1984
-
Effects of Diethyldithiocarbamate and Nine Other Nucleophiles on the Intersubunit Protein Cross-Linking and Inactivation of Purified Human α2-Macroglobulin by cis-Diamminedichloroplatinum(ll).
44:5764-5770.
1984
-
Effects of diethyldithiocarbamate and nine other nucleophiles on the intersubunit protein cross-linking and inactivation of purified human alpha 2-macroglobulin by cis-diamminedichloroplatinum(II)..
44:5764-5770.
1984
-
In vitro versus in vivo correlations of chemosensitivity of human medulloblastoma..
44:5145-5149.
1984
-
The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia..
44:4772s-4780s.
1984
-
Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia..
44:3593-3598.
1984
-
Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas..
44:2813-2819.
1984
-
Growth rate of control and beta-interferon-treated human fibroblast populations over the course of their in vitro life span..
44:2291-2296.
1984
-
Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations..
44:2352-2357.
1984
-
Absence of an effect of dietary corn oil content on plasma prolactin, progesterone, and 17 beta-estradiol in female Sprague-Dawley rats..
44:1420-1425.
1984
-
Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine..
44:1530-1535.
1984
-
Human leukemia cell lines with comparable receptor binding characteristics but different phenotypic responses to phorbol diesters..
44:976-980.
1984
-
EFFECTS OF DIETHYLDITHIOCARBAMATE AND 9 OTHER NUCLEOPHILES ON THE INTERSUBUNIT PROTEIN CROSS-LINKING AND INACTIVATION OF PURIFIED HUMAN ALPHA-2-MACROGLOBULIN BY CIS-DIAMMINEDICHLOROPLATINUM(II).
44:5764-5770.
1984
-
Importance of minimum tumor temperature in determining early and long-term responses of spontaneous canine and feline tumors to heat and radiation..
44:43-50.
1984
-
THE UTILITY OF THERMAL DOSE AS A PREDICTOR OF TUMOR AND NORMAL TISSUE RESPONSES TO COMBINED RADIATION AND HYPERTHERMIA.
44:4772-4780.
1984
-
THE UTILITY OF THERMAL DOSE AS A PREDICTOR OF TUMOR AND NORMAL TISSUE RESPONSES TO COMBINED RADIATION AND HYPERTHERMIA.
44:4772-4780.
1984
-
The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia.
44.
1984
-
Correlation between Initial and Long-Term Responses of Spontaneous Pet Animal Tumors to Heat and Radiation or Radiation Alone.
43:5735-5741.
1983
-
Correlation between initial and long-term responses of spontaneous pet animal tumors to heat and radiation or radiation alone..
43:5735-5741.
1983
-
Microwave hyperthermia and its effect on tumor blood flow in rats..
43:4665-4669.
1983
-
Phase I study of pharmacological and immunological effects of human lymphoblastoid interferon given to patients with cancer..
43:4458-4466.
1983
-
Association of the human type C retrovirus with a subset of adult T-cell cancers..
43:3892-3899.
1983
-
Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice..
43:3088-3093.
1983
-
Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies..
43:3327-3334.
1983
-
Regional measurements of blood flow in experimental RG-2 rat gliomas..
43:3362-3367.
1983
-
Regional measurements of blood-to-tissue transport in experimental RG-2 rat gliomas..
43:3368-3373.
1983
-
S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine..
43:3451-3458.
1983
-
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody..
43:2796-2805.
1983
-
Hormonal and metabolic regulation of human chondrosarcoma in vitro..
43:513-516.
1983
-
Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody..
43:736-742.
1983
-
Spatial distribution of proliferating cells in avian sarcoma virus-induced gliomas..
43:456-459.
1983
-
CORRELATION BETWEEN INITIAL AND LONG-TERM RESPONSES OF SPONTANEOUS PET ANIMAL TUMORS TO HEAT AND RADIATION OR RADIATION ALONE.
43:5735-5741.
1983
-
Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state..
42:3607-3616.
1982
-
Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen..
42:1215-1222.
1982
-
Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies..
42:601-608.
1982
-
Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies..
42:267-275.
1982
-
Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas..
42:168-177.
1982
-
Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools..
41:4493-4498.
1981
-
Southwest Oncology Group Experience with Immunological Phenotyping in Acute Lymphocytic Leukemia of Childhood.
41:4802-4809.
1981
-
Mammary Carcinogenesis In Rats Fed Different Amounts And Types Of Fat.
41:3735-3737.
1981
-
Mammary carcinogenesis in rats fed different amounts and types of fat..
41:3735-3737.
1981
-
Growth inhibition by thymidine of leukemic HL-60 and normal human myeloid progenitor cells..
41:2141-2146.
1981
-
Activation of cyclophosphamide for in vitro testing of cell sensitivity..
40:4443-4445.
1980
-
An in vitro assay procedure to test chemotherapeutic drugs on cells from human solid tumors..
40:4438-4442.
1980
-
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor-dependent Mechanisms during Anti-CD20 Antibody Immunotherapy.
40:4775-4780.
1980
-
Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells..
40:1002-1005.
1980
-
Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease..
40:557-562.
1980
-
IMMUNOTHERAPY OF MURINE LEUKEMIA .3. ABSENCE OF MACROPHAGE INVOLVEMENT IN THE PASSIVE SERUM THERAPY OF FRIEND-LEUKEMIA VIRUS-INDUCED DISEASE.
40:557-562.
1980
-
Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis..
39:4810-4815.
1979
-
Surface antigens of human glioma cells shared with normal adult and fetal brain..
39:3235-3243.
1979
-
Morphological and biochemical properties of a new human breast cancer cell line..
39:2604-2613.
1979
-
Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia..
39:1635-1639.
1979
-
Dihydrofolate Reductase in Primary Brain Tumors, Cell Cultures of Central Nervous System Origin, and Normal Brain during Fetal and Neonatal Growth.
39:487-491.
1979
-
Dihydrofolate reductase in primary brain tumors, cell cultures of central nervous system origin, and normal brain during fetal and neonatal growth..
39:487-491.
1979
-
DIHYDROFOLATE-REDUCTASE IN PRIMARY BRAIN TUMORS, CELL-CULTURES OF CENTRAL NERVOUS-SYSTEM ORIGIN, AND NORMAL BRAIN DURING FETAL AND NEONATAL GROWTH.
39:487-491.
1979
-
Cytotoxic and metabolic effects of adenosine and adenine on human lymphoblasts..
38:2357-2362.
1978
-
Tumor membrane lymphocyte stimulation assay in patients with renal cell carcinoma..
38:1447-1456.
1978
-
General immunocompetence of rats bearing avian sarcoma virus-induced intracranial tumors..
38:74-77.
1978
-
Surface antigenic characteristics of human glial brain tumor cells..
37:4267-4275.
1977
-
Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice..
37:4049-4058.
1977
-
Antigens shared by rat schwannomas, neuroblastomas, and a testicular interstitial cell carcinoma..
37:3379-3384.
1977
-
Development and application of basic research techniques in bladder cancer research..
37:2969-2973.
1977
-
Influence of age at inoculation on avian oncornavirus-induced brain tumor incidence, tumor morphology, and postinoculation survival in F344 rats..
37:1657-1661.
1977
-
Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines..
37:922-930.
1977
-
Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on the surfaces of normal murine cells..
37:931-938.
1977
-
Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.
36.
1976
-
Virus-infected avian cell lines established in vitro..
36:3894-3904.
1976
-
Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells..
36:3217-3224.
1976
-
Potential leukemia virus subunit vaccines: discussion..
36:655-656.
1976
-
Virus-infected Avian Cell Lines Established in Vitro.
36:3894-3904.
1976
-
Characterization of a chimpanzee anti-human melanoma antiserum..
35:2132-2137.
1975
-
Serial labeling index determination as a predictor of response in human solid tumors..
35:1438-1444.
1975
-
Some properties of a DNA-unwinding protein unique to lymphocytes from chronic lymphocytic leukemia..
35:981-986.
1975
-
An ultrastructural study of C-type virion assembly in mouse cells..
34:3303-3310.
1974
-
A determination of the outer dimensions of oncornaviruses by several electron microscopic procedures..
34:1694-1706.
1974
-
In vitro determination of thymidine-3H labeling index in human solid tumors..
34:1376-1380.
1974
-
Isolation of a transplantable cell line induced by the MC29 avian leukosis virus..
34:1457-1464.
1974
-
Specificity, cross-reactivity, and affinity of 125I-labeled antiglioma antibodies for monolayers of cultured glioma cells..
33:2362-2372.
1973
-
Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma..
32:2711-2716.
1972
-
Response of bone marrow to MC29 avian leukosis virus in vitro..
29:2056-2074.
1969
-
Studies on the distribution of blood flow in amelanotic melanoma and reticulum cell lymphosarcoma during growth..
28:1507-1512.
1968
-
Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus..
27:1138-1157.
1967
-
Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer..
54:362-364.
1994
-
Abstract P1-22-02: Subsequent risk of ipsilateral breast events in a multinational DCIS cohort of 48.619 patients: A meta-analysis within the PRECISION consortium
2022
-
Abstract P2-08-08: Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer
2022
-
Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction
2022
-
Abstract P5-13-29: Analytical and clinical validation of a ctDNA assay for detecting copy number loss and structural rearrangement variants contributing to homologous recombination and repair (HRR) deficiency
2022
-
Associations of inflammatory biomarkers with survival among patients with stage III colon cancer (CALGB/SWOG 80702 [Alliance])
2022
-
CD8 T cell mediated killing of MHC class 1 negative tumors requires antigen presenting myeloid cells and interferon gamma
2022
-
Copy number analysis of pure DCIS and association with recurrence
2022
-
Dormant mammary tumors resist antigen-specific killing and regulate systemic immunity in association with PTN and DKK3
2022
-
Dual energy analysis of TKI response in GIST - results of a prospective trial
2022
-
Durable clinical and radiographic responses in a series of patients with HER2+Breast Cancer (BC) Leptomeningeal Disease (LMD) treated with trastuzumab deruxtecan (T-DXd)
2022
-
Durable clinical and radiographic responses in a series of patients with HER2+Breast Cancer (BC) Leptomeningeal Disease (LMD) treated with trastuzumab deruxtecan (T-DXd).
2022
-
Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma
2022
-
Extended human papillomavirus genotyping to predict progression to high-grade cervical precancer: A prospective cohort study in the southeastern United States
2022
-
Influence of geographic/ancestral origin on glioma incidence and outcomes in US Hispanics
2022
-
Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC
2022
-
Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment
2022
-
Reciprocal Sox2 regulation by SMAD1 and SMAD3 is critical for anoikis resistance and metastasis in ovarian cancer
2022
-
Resolution of obesity-driven proinflammatory adipose signaling by weight loss or an NSAID is associated with reduced tumor burden in a mouse model of colon cancer
2022
-
Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression
2022
-
Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients
2022
-
Targeting a metabolic compensatory mechanism for heat shock factor 1 inhibition in prostate cancer
2022
-
Targeting transcriptional co-activators YAP1/TAZ in fusion-positive rhabdomyosarcoma demonstrates a novel strategy in ablating fusion-driven sarcoma transcriptional programing
2022
-
The GPCR OR13A1 is essential for lymphoma cells
2022
-
The Nrf2(E79Q) activating mutation accelerates growth of pure-small cell lung cancer but not combined small cell lung cancer Tp53(floxed/floxed)/Cdkn2a(floxed/floxed) mice
2022
-
Characterization of underlying genomic features among African ancestry populations diagnosed with chronic lymphocytic leukemia.
2021
-
Chemotherapy-induced nausea and vomiting (CINV) risk after prior breakthrough CINV: Unmasking the false average
2021
-
Duration of chemotherapy-induced nausea and vomiting (CINV) as a predictor of later-cycle CINV
2021
-
Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan
2021
-
From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy.
2021
-
Identification of pathogenic FGFR1, FGFR2, and FGFR3 alterations in cell-free DNA (cfDNA) from patients with metastatic breast cancer
2021
-
Identification of pathogenic RET alterations in cell-free DNA (cfDNA) from patients with metastatic breast cancer
2021
-
Inflammation and coagulation biomarkers associated with physical resilience in older women receiving chemotherapy for early breast cancer
2021
-
Intratumoral delivery of tavokinogene telseplasmid (plasmid IL-12) and electroporation induces an immune signature that predicts successful combination in patients
2021
-
Intratumoral plasmid IL-12 enhanced the systemic anti-tumor effect of anti-PD-1 antibody in triple-negative breast cancer.
2021
-
Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ in patients with and without index surgery: The effects of endocrine therapy and radiation treatment
2021
-
LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.
2021
-
LUMINOS-103: A basket trial evaluating the safety and efficacy of PVSRIPO in patients with advanced solid tumors.
2021
-
Links between obesity and secreted frizzled-related protein 4 (Sfrp4) in a murine model of colon cancer.
2021
-
Nci 10013-A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel, with or without atezolizumab in triple negative breast cancer (TNBC)
2021
-
Rurality and neighborhood socioeconomic deprivation associated with patient-reported outcomes andsurvivalin men with prostate cancer in NRG RTOG 0415.
2021
-
Snord67 promotes lymph node metastasis through U6-mediated alternative splicing in breast cancer
2021
-
Abstract PO-002: Detection of chemotherapy-resistant pancreatic cancer using a glycan Biomarker
2020
-
Abstract 1180: Estimating the contribution of epidemiologic risk factors to racial differences in epithelial ovarian cancer incidence
2020
-
Abstract 2033: Reducing cancer caregiver burden: A user-centered design approach for an mHealth app
2020
-
Abstract 2327: Genetic correlation analysis identifies glioma heritability enrichment in immune cell types and novel protective associations with auto-immune conditions
2020
-
Abstract 2502: Genetic and functional heterogeneity of DCIS as predictors of invasive cancer
2020
-
Abstract 3507: Race-related genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer
2020
-
Abstract 3882: YAP1 and WWTR1 (TAZ) positively regulate PAX3-FOXO1 transcriptional programming in fusion-positive rhabdomyosarcoma
2020
-
Abstract 5243: Averting tumor growth in rodent breast cancer models with a liquid ablation approach
2020
-
Abstract 5719: Tumor-suppressive stromal activity of pro-fibrogenic microRNA-21 in initiation and progression of K-Ras-driven mouse models of pancreatic cancer
2020
-
Abstract 5821: The role of SMARCAL1
loss-of-function mutations in glioblastoma telomere maintenance
2020
-
Abstract 6406: FAK and MEK co-targeting: A new multimodal precision therapy for GNAQ
-driven uveal melanoma
2020
-
Abstract 6439: CapioCyte™ technology for efficient capture and downstream analysis of circulating tumor cells from renal cell carcinoma
2020
-
Abstract 6536: Safety and efficacy of autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccination in combination with systemic therapies in patients with metastatic melanoma
2020
-
Abstract 6630: Synergistic immuno photothermal nanotherapy (SYMPHONY) for combination cancer therapy
2020
-
Abstract 904: Stimulation and expansion of oncogene-reactive tumor infiltrating T cells through combined Ad-HER2Δ16 vaccination and anti-PD1 enable anti-tumor responses against established HER2 BC
2020
-
Abstract GS2-05: Microscaled proteogenomic methods for precision oncology
2020
-
Abstract OT1-05-01: The incidence of febrile neutropenia (FN) for chemotherapy patients receiving pegfilgrastim by an on-body injector (pegfilgrastim OBI) versus other FN prophylaxis strategies
2020
-
Abstract P1-03-03: Multichannel serial imaging of transgenic, preclinical murine models provides the first quantitative analysis of the unusual growth kinetics and lymph-vascular invasion of patient-derived inflammatory breast cancer cells and tumor emboli
2020
-
Abstract P1-06-02: Characterization of gene- and sample-level APOBEC mutagenesis enrichment with respect to intrinsic subtypes, tumor mutational burden, and immune composition in breast cancer
2020
-
Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts
2020
-
Abstract P1-21-07: The Patient-reported Outcomes after Routine Treatment of Atypical Lesions (PORTAL) study: Pain, psychosocial wellbeing, and quality of life among women undergoing guideline concordant care for DCIS vs. active surveillance for in situ and atypical lesions
2020
-
Abstract P2-10-18: Deciphering racial disparities in breast cancer collagen reorganization by targeted extracellular matrix proteomics
2020
-
Abstract P3-06-09: Incidence of ROS1 genomic alterations in breast cancer
2020
-
Abstract P3-08-10: Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER+/HER-, lymph node negative breast cancer
2020
-
Abstract P4-05-03: Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
2020
-
Abstract P4-12-10: Clinical implementation of the machine learning-based automated treatment planning tool for whole breast radiotherapy
2020
-
Abstract P5-14-07: Avoidable acute care involving chemotherapy-induced nausea and vomiting (CINV) among patients with breast cancer receiving anthracycline + cyclophosphamide (AC) with NEPA prophylaxis relative to other antiemetics: An external control arm analysis
2020
-
Abstract P5-14-11: Cardiac monitoring in advanced breast cancer patients treated with trastuzumab: Does it improve cardiac safety?
2020
-
Abstract P5-14-17: Musculoskeletal side effects over time and association with adherence in women taking neoadjuvant letrozole for estrogen receptor positive DCIS: CALGB 40903 (Alliance)
2020
-
Abstract P5-14-18: Cardioprotective therapy in breast cancer patients with subclinical and clinical cardiotoxicty
2020
-
Abstract PD10-10: Factors associated with decreased relative dose intensity in older adults with early-stage breast cancer receiving chemotherapy
2020
-
Dynamic single-cell imaging of human cancer growth and therapy responses following engraftment into immunodeficient zebrafish.
2020
-
Incidence and trends in head and neck cancer among United States' pediatric, adolescent, and young adult population
2020
-
Inferring the evolutionary dynamics of ductal carcinoma in situ through multi-regional sequencing and mathematical modeling.
2020
-
Parallel targeting of RAF/MEK/ERK pathway in RAS-mutant embryonal rhabdomyosarcoma
2020
-
The immune profile of sentinel lymph nodes in melanoma.
2020
-
Abstract 1149: Systems pathology by Optra 30 color multiplex immunofluorescence automated whole slide imaging system integrated with image analysis
2019
-
Abstract 1675: Analytical validation of MSI High detection with GuardantOMNI
2019
-
Abstract 2667: Genetic removal of metazoan SpoT homolog I (MESH1) inhibits proliferation through the repression of HIPPO effector TAZ
2019
-
Abstract 2745: Tumor microenvironment and host genetics impact glioma progression in a Collaborative Cross-based orthotopic allograft model
2019
-
Abstract 3590: Mechanisms and inhibition RIOK2 for obesity-driven prostate cancer
2019
-
Abstract 3670: Transcriptional co-activators TAZ/YAP are novel regulators of PAX3-FOXO1 transcriptional programing and fusion-positive rhabdomyosarcoma cancer cell stemness
2019
-
Abstract 3731: A novel heat shock protein 90-targeted photosensitizer (HS-201) enables enhanced tumor-specific photodynamic therapy of inflammatory breast cancers
2019
-
Abstract 4071: A novel combination therapy of high intensity focused ultrasound and PDL1 blockades against advanced breast cancer
2019
-
Abstract 4173: Previously identified common glioma risk SNPs are associated with familial glioma
2019
-
Abstract 4215: Patient and screening characteristics associated with positive lung cancer screening examinations
2019
-
Abstract 4472: The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma
2019
-
Abstract 4515: Utilizing nucleic-acid scavengers (NASs) to inhibit proinflammatory and proinvasive signaling in triple-negative breast cancer
2019
-
Abstract 4900: Dynamic metabolic response of prostate cancer patients treated with ADT and low carb diet
2019
-
Abstract 750: Ancestry-related differentially spliced and expressed genes in prostate cancer
2019
-
Abstract 862: Inhibition of Hippo tumor suppressors MST1/2 slows prostate cancer cell proliferation and invasion
2019
-
Abstract CT135: Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reported KRAS, NRAS, BRAF
mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
2019
-
Abstract CT146: Sunitinib (S) in patients (Pts) with metastatic colorectal cancer (mCRC) with FLT-3
alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
2019
-
Abstract CT162: Pembrolizumab monotherapy for the adjuvant treatment of renal cell carcinoma post-nephrectomy: Randomized, double-blind, Phase III KEYNOTE-564 study
2019
-
Abstract CT220: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer
2019
-
Abstract LB-103: Defining oncogenic SWI/SNF complex mediated immune reprogramming in squamous cell carcinoma
2019
-
Abstract LB-235: COLOMATE: Colorectal cancer and liquid biopsy screening protocol for molecularly assigned therapy
2019
-
Abstract LB-287: Combination therapies with CDK4/6 inhibitors to treat KRAS-
mutant pancreatic cancer
2019
-
Abstract ES10-3: Blockade of estrogen signaling boosts antitumor immunity by inhibiting tumor-induced pathological myelopoiesis
2019
-
Abstract P1-06-04: Small-molecule screening nominates diverse combination therapies that sensitize BRCA mutant and wild-type triple negative breast cancer to PARP inhibition
2019
-
Abstract P2-09-16: CD8 T cells induced by novel alphaviral vector predict improved progression free survival in advanced HER2+ breast cancer patients
2019
-
Abstract P3-06-12: Genetic heterogeneity of DCIS is a predictor of invasive cancer
2019
-
Abstract P3-08-07: Distinct biological signatures describe differences in BRCA mutated subgroups
2019
-
Abstract P4-16-05: Avoidable acute care use associated with nausea and emesis among patients receiving AC, carboplatin, or cisplatin for breast cancer
2019
-
Abstract P4-16-09: Effect of simvastatin on cardiac strain in breast cancer patients receiving anthracycline therapy
2019
-
Abstract PD6-08: Medicare costs for women after breast cancer: Preparing for survivorship
2019
-
Abstract A47: Inhibition of histone methyltransferase with novel epipolythiodioxopiperazines (ETP) alkaloids in pediatric high-grade glioma
2018
-
Abstract A031: Androgen deprivation therapy-induced TGFBI signaling promotes EMT and bone metastasis of prostate cancer
2018
-
Abstract B038: Convergent hormone therapy resistance mediated by stress/dormancy-like pathways in prostate cancer
2018
-
Alternative RNA splicing and prostate cancer aggressiveness.
2018
-
Defining new drivers of castration- resistant prostate cancer
2018
-
Oncogenic convergence of normal human prostate epithelial cells to a small cell neuroendocrine phenotype.
2018
-
Stem cell-directed pan-cancer analysis reveals a human adult stem cell signature that defines aggressive epithelial cancer subtypes.
2018
-
Abstract 1695: A multi-institutional study to evaluate automated scoring of immunohistochemistry slides for assessment of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer
2018
-
Abstract 1805: Development of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer
2018
-
Abstract 2255: Using tumor sample gene expression data to infer tumor purity levels with stochastic gradient boosting machines
2018
-
Abstract 233: Evaluating glioma risk associated with extent of European admixture in African-Americans and Latinos
2018
-
Abstract 2813: Efficacy and pharmacokinetics of niraparib in BRCA
-mutant and wild-type intracranial triple negative breast cancer murine models
2018
-
Abstract 3229: Prediagnostic biomarkers of metabolic dysregulation and cancer mortality
2018
-
Abstract 388: p16/MTAP status as a model for investigating gene-environment interactions in metabolism
2018
-
Abstract 4152: Synergistic gold nanostar-mediated photothermal and immunotherapy for cancer metastasis treatment
2018
-
Abstract 4220: Heterogeneous distribution of prognostic protein markers in glioblastoma
2018
-
Abstract 4854: Targeting ribonucleotide reductase M2 using didox causes inhibition of estrogen receptor-negative, inflammatory breast cancer cell proliferation and tumor emboli formation in culture
2018
-
Abstract 5068: Distinct pro-inflammatory cytokines in prostate fibroblasts from African-Americans with prostate cancer increase the tumorigenicity of cancer cells
2018
-
Abstract 5256: A prospective study of inflammatory diet potential and risk of hepatocellular carcinoma (HCC)
2018
-
Abstract 5318: High-grade serous ovarian cancer DNA methylation and survival in African-American women
2018
-
Abstract 5474: Activity of the S1P pathway promotes ovarian cancer and serves as a novel metabolic target of metformin
2018
-
Abstract 5496: A predictive model for selective targeting of the Warburg effect through GAPDH inhibition with a natural product
2018
-
Abstract 5497: Effective combination therapy for breast cancer targeting BACH1 and mitochondrial metabolism
2018
-
Abstract 5551: SGN-2FF: A small-molecule inhibitor of fucosylation modulates immune cell activity in preclinical models and demonstrates pharmacodynamic activity in early phase 1 analysis
2018
-
Abstract 5702: Characterization of circulating tumor cells during immune checkpoint inhibition in metastatic renal cell carcinoma and malignant melanoma
2018
-
Abstract LB-302: Oncolytic poliovirus-mediated inflammation and immunity in breast cancer
2018
-
Abstract SY01-02: Blockade of estrogen signaling boosts antitumor immunity by dwindling cancer-promoting myelopoiesis
2018
-
Abstract PR09: Clonal dynamics during breast cancer dormancy and recurrence
2018
-
Detection of mutations in single tumor cells collected by fine needle aspiration in a mouse xenograft breast cancer model using MALDI-TOF
2018
-
Incidence and mortality among breast cancer patients < 40 years old: US trends from 1992-2014
2018
-
Is it cancer or not? A qualitative exploration of patient perspectives surrounding the diagnosis and treatment of DCIS
2018
-
Prediction of occult invasive disease in ductal carcinoma in situ using deep learning features
2018
-
Primary endocrine therapy for ER-positive ductal carcinoma in situ (DCIS) CALGB 40903 (Alliance)
2018
-
Quantifying the natural history and overtreatment rate of ductal carcinoma in situ
2018
-
Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study
2018
-
Abstract 1172: In vivo
pharmacokinetic properties and antitumor efficacy of porcupine lead inhibitors in the orthotopic murine MMTV-Wnt1 breast tumor model and the human HPAF-II pancreatic xenograft mouse model
2017
-
Abstract 1289: Evaluation of vitamin D receptor regulated genes reveals EGFR polymorphism is associated with high-grade serous ovarian cancer in African American women
2017
-
Abstract 1302: Genome-wide association study of glioma reveals specific differences in genetic susceptibility to glioblastoma and non-glioblastoma
2017
-
Abstract 1315: Estimating sex-specific effects of genetic loci associated with glioma risk
2017
-
Abstract 1859: Hsp90 targeted near infrared molecular imaging to detect mammografically occult invasive lobular breast cancer
2017
-
Abstract 1991: Enhanced role of the extracellular matrix in ovarian cancer recurrence
2017
-
Abstract 2272: A prospective study of urinary prostaglandin E2 metabolite, Helicobacter pylori
antibodies, and gastric cancer risk
2017
-
Abstract 268: Tracking HPV vaccination of young boys: is parental recall as dependable as physician records
2017
-
Abstract 2796: Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity
2017
-
Abstract 2810: Using CRISPR/Cas9 to generate primary soft tissue sarcoma in genetically engineered and wild-type mice
2017
-
Abstract 3187: Role of exosome secretion in the survival of enzalutamide-resistant prostate cancer cells: Syntaxin 6 as a novel therapeutic target
2017
-
Abstract 3707: Tumor-associated neutrophils with antigen-presenting features in early-stage human lung cancer
2017
-
Abstract 4221: Factors associated with HPV vaccination initiation and completion among 18-26 year olds in the United States
2017
-
Abstract 4243: Epigenome-wide association study of metabolic syndrome in African-Americans
2017
-
Abstract 4709: Induction of enhanced tumor-specific immunity by Hsp90 targeted photodynamic therapy (Hsp90-PDT) combined with immune checkpoint inhibition
2017
-
Abstract 5457: OGT restrains the NRF2 antioxidant pathway via O-GlcNAcylation of KEAP1
2017
-
Abstract 5830: A novel Notch-YAP circuit drives stemness and tumorigenesis in embryonal rhabdomyosarcoma
2017
-
Abstract 588: Advanced molecular characterization of severe autoimmune toxicities associated with checkpoint inhibitor therapies
2017
-
Abstract 666: CD37 tetraspanin as a novel biomarker for PD-1 blockade in diffuse large B-cell lymphoma
2017
-
Abstract CT047: Phase 1 dose-escalation study of the CDK inhibitor dinaciclib in combination with the PARP inhibitor veliparib in patients with advanced solid tumors
2017
-
Abstract OT1-04-06: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer
2017
-
Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial
2017
-
Abstract P1-05-30: Genomic and microenvironmental intra-tumor heterogeneity in DCIS
2017
-
Abstract P1-06-06: Evidence for tumor heterogeneity and clonal evolution during invasive progression of breast cancer
2017
-
Abstract P2-04-19: Elucidating the tumor immune microenvironment phenotype in early stage untreated BRCA mutated breast cancer patients
2017
-
Abstract P2-04-27: CTLA-4 and PD-1 checkpoint inhibitors enhance individually tailored adaptive anti-tumor immune responses to overcome tumor immunosuppression and effectively treat triple-negative breast cancer
2017
-
Abstract P3-07-14: Targeting ERR-α regulated lactate metabolism eliminates drug-resistant breast cancer cells
2017
-
Abstract P3-16-02: Nanotheranostics using plasmonic gold nanostars to target inflammatory breast cancer cells and tumor emboli
2017
-
Abstract P4-19-01: Non-metastatic and metastatic breast cancer patients' priorities when considering a treatment decision
2017
-
Abstract P4-22-02: Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V+TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1
or BRCA2
mutations and metastatic breast cancer
2017
-
Abstract P5-08-12: HER2 status remains the primary predictor of improved survival in patients with BCBM over the past 2 decades (1996-2015)
2017
-
Abstract PD1-03: Multivariate analysis of subtype and gene expression signatures predictive of pathologic complete response (pCR) in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
2017
-
Abstract S2-05: Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1
or BRCA2
mutations and metastatic breast cancer: A randomized, phase 2 study
2017
-
Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
2017
-
Abstract A16: Smad4 pathways modulate induction of the chemokine Ccl20 and repress inflammation-induced carcinogenesis in mouse colon
2017
-
Abstract A02: The origin and role of APC-like hybrid tumor-associated neutrophils in early-stage human lung cancer
2016
-
Abstract 1182: Heparin-binding epidermal growth factor-like growth factor is a pro-differentiating factor in neuroblastoma
2016
-
Abstract 129: Integrated genomic analysis of survival outliers in glioblastoma
2016
-
Abstract 1430: Do race and gender independently predict risk factors associated with the Human papillomavirus
2016
-
Abstract 1647: Radiation response genome-wide analysis using paired pre and post-radiation FFPE human breast tumor samples
2016
-
Abstract 1656: Subtype-specific radiation response in human breast cancer and potential therapeutic effect of FAS death receptor modulation
2016
-
Abstract 1735: Fruit and vegetable consumption and risk of gastric cancer: a prospective nested case-control study in China, Japan and Korea
2016
-
Abstract 1754: Body powder use and ovarian cancer: the African American Cancer Epidemiology Study
2016
-
Abstract 1771: Metabolic dysregulation and cancer mortality in a national cohort of African-Americans and whites
2016
-
Abstract 1785: Sociodemographic correlates of knowledge and risk perception of HPV and HPV-associated oropharyngeal cancer
2016
-
Abstract 1787: Adolescent boys and the human papillomavirus (HPV) - Geographical patterns of vaccination uptake
2016
-
Abstract 1852: Multiple PI3K pathway mutations predominate in low stage endometrial carcinomas
2016
-
Abstract 2037: A discovery study to identify clinical and genetic risk factors for bevacizumab (BEV)-related gastrointestinal (GI) hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated on CALGB 90401 (Alliance)
2016
-
Abstract 2393: Kidneys of VHL patients reveal the origin of renal clear cell carcinoma
2016
-
Abstract 2577: A comparison of parent and provider verified HPV vaccination initiation and completion in US adolescents: findings from the National Immunization Survey - Teen, 2014
2016
-
Abstract 2691: Genome-wide association study identifies two susceptibility loci that modify radiation-related risk for breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study and St. Jude Lifetime Cohort
2016
-
Abstract 3388: Genetic prediction of VEGF-A plasma levels in cancer patients
2016
-
Abstract 3407: Gene expression subtypes of high grade serous ovarian cancer in African American women
2016
-
Abstract 3417: Peripheral CD8+CD28-suppressive T lymphocytes act as a prognosticator among breast cancer patients with adoptive T-cell immunotherapy
2016
-
Abstract 3472: Does being married independently predict survival in patients with head and neck cancer? Results from a single institution
2016
-
Abstract 3867: Combined PI3K and AURKA inhibition are efficacious in triple-negative breast cancer models
2016
-
Abstract 4480: Blood epigenetic age may predict cancer incidence and mortality
2016
-
Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer
2016
-
Abstract LB-015: XIAP induction by the MAPK-eIF4G1 pathway drives NFκB activation in inflammatory breast cancer growth and therapeutic resistance
2016
-
Abstract LB-361: Serology of Streptococcus gallolyticus subsp. gallolyticus and risk of colorectal cancer
2016
-
Abstract SY22-02: Exercise and cancer progression: Preclinical evidence
2016
-
Dietary patterns and cancer mortality among African Americans and Whites in the REGARDS cohort
2016
-
Abstract ES8-3: Endocrine management of premalignant lesions and DCIS
2016
-
Abstract OT3-03-04: NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) &/or surgical ablation for newly oligometastatic breast cancer
2016
-
Abstract P3-14-04: Effects of the dual selective CYP17 lyase inhibitor and androgen receptor (AR) antagonist, VT-464, on AR+ and ER+ tumor models in vitro and in vivo
2016
-
Abstract P4-08-03: DEAD-box RNA helicase DP103 as a novel regulator of Wnt/β-catenin signaling pathway and promotes cancer stem cell-like behavior in triple negative breast cancers
2016
-
Abstract P4-09-16: A monoclonal antibody with exceptional specificity across major breast cancer subtypes
2016
-
Abstract P4-13-25: Abemaciclib, an inhibitor of CDK4 and CDK6, combined with endocrine and HER2-targeted therapies for women with metastatic breast cancer
2016
-
Abstract P4-14-16: T-cell clonality increases after neoadjuvant treatment with trastuzumab and pertuzumab
2016
-
Abstract P5-17-03: The 12-gene DCIS score assay: Impact on radiation treatment (XRT) recommendations and clinical utility
2016
-
Abstract P6-04-11: The foundation one assay influences clinical decision making in metastatic breast cancer
2016
-
Abstract P6-05-03: Genomic diversity of ductal carcinoma in situ (DCIS) as a driver of invasion and metastasis
2016
-
Abstract S3-06: Treatment outcomes in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging: Results of a secondary analysis of TBCRC 017
2016
-
Abstract A12: Genomically unstable glioblastoma are sensitive to Parp inhibition
2015
-
Abstract 1100: Functional genomics to investigate the genetic determinants of cell death induced by oxidative stresses
2015
-
Abstract 1585: Application of a graphene oxide based microfluidic device (GO Chip) to prostate cancer circulating tumor cell capture and analysis
2015
-
Abstract 1610: Development of meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma
2015
-
Abstract 1809: Next-generation brachytherapy: a preclinical study of a thermally stabilized biopolymer gel for delivering intratumoral radionuclide therapy in a pancreatic tumor mouse model
2015
-
Abstract 1847: AR-V7 regulation during epithelial plasticity
2015
-
Abstract 2236: Emergence of epigenetic regulation of tight junction genes in recurrent serous epithelial ovarian cancer
2015
-
Abstract 2579: Combination therapy with MEK inhibition is efficacious in intracranial triple negative breast cancer models
2015
-
Abstract 2703: Overcoming Lapatinib resistance by the fatty acid synthase inhibitor HS-106
2015
-
Abstract 3004: Contextual RNAi screen identifies ACLY and ACC1 as mediators of hypoxia-induced apoptosis through metabolic and transcriptional mechanisms
2015
-
Abstract 3212: Metastatic breast cancer cell communication within a pro-dormancy bone marrow niche
2015
-
Abstract 3302: Subtype-specific radiation response in a mouse model of human breast cancer
2015
-
Abstract 3331: Gene expression profiling after radiation in human breast cancer specimens and breast cancer cell lines
2015
-
Abstract 3732: Detecting germline PTEN mutations among at-risk cancer patients: An age and gender-specific cost effectiveness analysis
2015
-
Abstract 3830: Employing reduced representation bisulfite sequencing for biomarker discovery in colorectal cancer
2015
-
Abstract 3912: GDF2 promotes anoikis susceptibility in ovarian and breast epithelia
2015
-
Abstract 4449: A novel Porcupine inhibitor is effective in the treatment of cancers with RNF43 mutations
2015
-
Abstract 4633: Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk
2015
-
Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk
2015
-
Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility
2015
-
Abstract 4636: Investigation of exome variants associated with overall survival in ovarian cancer
2015
-
Abstract 5465: Systematic interrogation of druggable pathways in pancreatic adenocarcinomas using pooled gene-knockdown lentiviral libraries
2015
-
Abstract 891: FGF21 prevents high fat diet-induced pancreatic cancer in mice expressing oncogenic Kras
2015
-
Abstract LB-087: A facilitative role for caspase 3 in promoting genetic instability and carcinogenesis
2015
-
Abstract SY36-03: Intraoperative molecular imaging with protease-activated fluorescent imaging agents
2015
-
Abstract B98: Final results of a randomized phase Ib study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior therapies
2015
-
Abstract P1-10-02: Adjuvant radiation after lumpectomy: A cost comparison of treatment patterns in 43,247 women from the National Cancer Data Base
2015
-
Abstract P1-10-04: Post-operative imaging after atypical ductal hyperplasia excision: The findings and costs
2015
-
Abstract P1-15-10: Low utilization of hypofractionated radiotherapy for the treatment of early-stage breast cancer in the US
2015
-
Abstract P2-12-07: The association between exercise behavior and patient-reported outcomes in women with early breast cancer receiving locoregional radiation therapy
2015
-
Abstract P3-07-22: Predictors of neoadjuvant chemotherapy use in women with breast cancer: A review of 169,329 patients from the American College of Surgeons' National Cancer Database
2015
-
Abstract P5-15-07: Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance]
2015
-
Abstract P6-07-06: Post-transcriptional coordination of gene expression during breast cancer tumorigenesis
2015
-
Abstract P6-14-05: A novel link between anti-apoptotic signaling, NFκB, and SMAD7 in IBC pathobiology
2015
-
Rates of adherence and persistence to adjuvant endocrine therapy among women enrolled in Medicare Part D in a four-state region of Appalachia
2015
-
A novel aptamer targeting agent for prostate cancer
2015
-
Abstract PR09: A genome-wide RNAi screen reveals a protective role of decreased lipogenesis under hypoxia
2015
-
Cancer associated macrophage-like cells as a blood-based biomarker for the screening of solid tumors
2015
-
Identification and treatment data of xenografts representing TCGA-defined glioblastoma subtypes
2015
-
Abstract IA11: New insights into DNA double-strand break responses
2014
-
Abstract A64: A role for injury in sarcomagenesis
2014
-
Abstract 1904: RNA expression based screening of ALK gene fusion from formalin fixed non-small cell lung cancer samples
2014
-
Abstract 2320: Clinical epigenetic resensitization of platinum-resistant, recurrent ovarian cancer patients with SGI-110, a novel, second-generation, subcutaneously administered hypomethylating agent (HMA)
2014
-
Abstract 2674: Stroma biology identifies heparins as differentiating agents in neuroblastoma
2014
-
Abstract 2970: Differential effects of caloric and carbohydrate restriction on prostate cancer in a mouse model
2014
-
Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma
2014
-
Abstract 3311: The cholesterol/ 27-hydroxycholesterol axis is a novel therapeutic target in castrate resistant prostate cancer
2014
-
Abstract 3536: Roles of miR-215 and regulatory mechanisms for its biogenesis in response to hypoxia in glioblastoma stem cells
2014
-
Abstract 3774: Hyperthermia treatment overcomes temozolomide resistance in glioma cells by downregulating MGMT
expression and increasing temozolomide uptake
2014
-
Abstract 3777: Combining VELIPARIB (ABT-888) with temozolomide shows strong synergy when treating temozolomide-resistant and recurrent GBM cell lines
2014
-
Abstract 3841: Bevacizumab (BEV) and risk of arterial (ATE) and venous thromboembolism (VTE) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401(ALLIANCE)
2014
-
Abstract 4117: Utilizing RNA aptamers for biomarker discovery in a novel cell culture system for hepatocellular carcinoma
2014
-
Abstract 4137: Latent class model characterization of neighborhood SES
2014
-
Abstract 4270: The use of mutational signatures in identifying carcinogen exposure
2014
-
Abstract 4481: Genetically encoded chimeric polypeptide nanoparticles for gemcitabine delivery to solid tumors
2014
-
Abstract 4518: The PI3K-δ inhibitor TGR-1202 induces cytotoxicity and inhibits phosphorylation of AKT in 17p deleted and non-17p deleted CLL cells in vitro
2014
-
Abstract 4570: Role of ERRalpha in ovarian cancer
2014
-
Abstract 4583: In situ photocontrolled intratumoral depot for combined photodynamic therapy and brachytherapy for solid tumor
2014
-
Abstract 4831: Breast cancer cells metastasize to bone through E-selectin+ vascular gateways
2014
-
Abstract 5168: Gastric adenocarcinomas show pervasive loss of heterozygosity and enrichment for “STOP” genes in regions of hemizygous deletion
2014
-
Abstract 518: Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers
2014
-
Abstract 5449A: PI3K and MEK inhibition in intracranial triple negative breast cancer: Efficacy of BKM120 and AZD6244 in preclinical mouse models
2014
-
Abstract 63: Driving brain tumorigenesis: Generation of a mutant IDH1 mouse model of progressive glioma
2014
-
Abstract 946: Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk
2014
-
Abstract CT238: Phase III randomized, placebo controlled trial of COX-2 inhibition in addition to standard chemotherapy for advanced non-small cell lung cancer (NSCLC):CALGB 30801 (Alliance)
2014
-
Abstract LB-123: Novel function of STAT1 pathway as a modulator of tumor progression in serous papillary endometrial cancer
2014
-
Abstract LB-292: Race-associated gene expression in tumors and breast cancer mortality disparities
2014
-
Abstract LB-89: Germ-line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
2014
-
AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganization
2014
-
Development of immunocytotoxic RNA therapeutics for human melanoma
2014
-
Establishment, identification and treatment data of TCGA glioblatoma xenograft subtypes
2014
-
Intratumoral administration of an Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) in recurrent glioblastoma(GBM): Preliminary results of the Phase I clinical trial
2014
-
MLL2 maintains neoplastic cell growth and global histone H3 lysine 4 monomethylation
2014
-
Abstract P2-16-13: Phase I dose escalation clinical trial of the PI3K inhibitor BKM120 and capecitabine (C) in metastatic breast cancer (MBC)
2013
-
Abstract P3-08-05: Chemotherapy-related amenorrhea on adjuvant paclitaxel-trastuzumab (APT trial)
2013
-
Abstract P5-14-04: Preoperative single-fraction partial breast radiotherapy – Initial results from a novel phase I dose-escalation protocol with exploration of radiation response biomarkers
2013
-
Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)
2013
-
Abstract S4-03: Exome sequencing reveals clinically actionable mutations in the pathogenesis and metastasis of triple negative breast cancer
2013
-
Abstract A48: Enhanced efficacy of cisplatin and 5-fluorouracil combination with AUY-922 in esophageal adenocarcinoma cells
2013
-
Abstract 1199: NSCLC KRAS G12C and G12V mutations drive different pathways and display specific drug sensitivity patterns.
2013
-
Abstract 1200: Molecular subtypes of gastric cancer show systematic differences in response to PI3K inhibitors and fluorouracil.
2013
-
Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry.
2013
-
Abstract 1367: Item response theory analysis of the patient satisfaction with cancer-related care: psychometric validation in a multicultural sample of 1,296 participants.
2013
-
Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands.
2013
-
Abstract 2079: Antitumoral activity of INC280 against adult glioblastoma brain tumors xenografts.
2013
-
Abstract 2564: Identification of a novel SPOP missense mutation from targeted next-generation sequencing of men with chromosome 17-q linkage.
2013
-
Abstract 330A: Differential expression of angiogenic genes in invasive high grade serous ovarian carcinomas.
2013
-
Abstract 352: Murine model of chordoma: Sonic Hedgehog promoter-driven Cre activation of Brachyury (T) expression induces spinal disk abnormalities and perinatal lethal developmental defects.
2013
-
Abstract 3647: Dose-dependent alteration of CpG methylation in AHRR
and GFI1
in mononuclear cell DNA of smokers.
2013
-
Abstract 364: Exercise slows tumor progression and normalizes tumor vasculature in murine models of breast cancer.
2013
-
Abstract 3698: Inhibition of cholesterol uptake with ezetimibe reduces intra-tumoral testosterone levels and slows tumor growth in transgenic mouse models of prostate cancer.
2013
-
Abstract 3914: In vivo
label-free examination of early-stage melanoma formation.
2013
-
Abstract 4341: A novel injectable polymer liquid that self-assembles into radioactive “seeds” for brachytherapy.
2013
-
Abstract 4479: Preclinical toxicology and pharmacology for BACPTDP, a camptothecin that targets hypoxic/acidic tumors.
2013
-
Abstract 4509: Genetically encoded chimeric polypeptide nanoparticles for paclitaxel delivery to triple negative breast cancer.
2013
-
Abstract 4598: Identification of driver genes in hepatocellular carcinoma by exome sequencing.
2013
-
Abstract 4707: Validation of survival prognostic models for non-small-cell lung cancer instage- and age-specific groups.
2013
-
Abstract 4767: Preclinical mouse model of recurrent epithelial ovarian cancer.
2013
-
Abstract 4850: Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness.
2013
-
Abstract 5041: The type III TGF-beta receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.
2013
-
Abstract 510: Activation of PP2A by SET antagonism destabilizes c-Myc and inhibits breast cancer growth.
2013
-
Abstract 5298: Two distinctive single nucleotide polymorphisms determine liver metastases responses to docetaxel plus thiotepa for metastatic breast cancer patients.
2013
-
Abstract 5354: Altered DNA methylation at imprinted insulin-like growth factor-2 (IGF2) resulting from heavy metal exposure in vitro
and in vivo
in infants from the newborn epigenetic study (NEST).
2013
-
Abstract 5521: Application of an automated capillary isoelectric-focusing immunoassay to study dynamic oncoprotein phosphorylation in non-small cell lung cancer and for evaluating drug response to targeted therapies.
2013
-
Abstract 5552: Manganese porphyrins in combination with ascorbate act as pro-oxidants and mediate caspase-independent cancer cell death.
2013
-
Abstract 5615: Evaluation of the antitumoral efficacy and toxicity of injectable, polymeric radionuclide seeds in a noninvasive preclinical prostate tumor model.
2013
-
Abstract 5681: Modulation of Wnt/β-catenin signaling by niclosamide and related derivatives.
2013
-
Abstract 951: Cross-resistance and re-sensitization to multiple drugs in an IBC model of lapatinib acquired resistance parallels redox adaptation.
2013
-
Abstract LB-161: A phase I safety study of NPC-1C, a novel, therapeutic antibody to treat pancreas and colorectal cancers.
2013
-
Abstract LB-164: Treatment of advanced stage colorectal cancer with ETBX-011 immunotherapeutic.
2013
-
Abstract LB-296: FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial.
2013
-
Efficacy of Sym004, a novel anti-EGFR antibody mixture, against EGFRvIII positive glioblastoma xenografts.
2013
-
Abstract P1-13-05: The association between timing in adjuvant chemotherapy administration and overall survival for women with breast cancer within the National Comprehensive Cancer Network (NCCN)
2012
-
Abstract P4-09-01: Retrospective evaluation of precision of gene-expression-based signatures of prognosis and tumor biology in replicate surgical biospecimens from patients with breast cancer
2012
-
Abstract P6-08-05: Changes in Cognitive Function in Older Women With Breast Cancer Treated with Standard Chemotherapy and Capecitabine within CALGB 49907
2012
-
Flat epithelial atypia diagnosed on breast core biopsy: what next?
2012
-
Patterns of definitive axillary management in the era prior to reporting ACOSOG Z0011: comparison between NCCN Centers and hospitals in Michigan
2012
-
Abstract 1027: Helicobacter pylori blood biomarkers for gastric cancer risk in the Shanghai Men's Health Study
2012
-
Abstract 1058: Mutations in isocitrate dehydrogenase 1 and 2 are associated with DNA hypermethylation in intrahepatic cholangiocarcinomas
2012
-
Abstract 1642: Rare missense variants in MAP3K14
and ARHGAP27
in men with hereditary prostate cancer
2012
-
Abstract 4766: The use of deuterium isotope effects to shift the partitioning of cyclophosphamide and ifosfamide among competing, P450-dependent, oxidative pathways
2012
-
Abstract 5255: Methionine restriction limits prostate tumor cell proliferation
2012
-
Abstract 5631: The effect of pomegranate extract dose on prostate cancer growth in a carbohydrate restricted mouse xenograft model
2012
-
Abstract LB-423: Whole genome comparisons of pre- and post- aromatase inhibitor treatment in estrogen receptor positive breast cancer
2012
-
The predictive value of a 5-gene signature as a patient pre-selection tool in medulloblastoma for Hedgehog pathway inhibitor therapy
2012
-
Glutamine synthetase is a genetic determinant of cell-type specific glutamine independence in breast epithelia
2012
-
Internalization of the dual-specific immunotoxin D2C7-(scdsFv)-PE38KDEL in malignant glioma cell lines
2012
-
The medulloblastoma oncogene Otx2 enhances migration and permits ectopic proliferation of neuronal progenitor cells of the cerebellum and brainstem
2012
-
The mutational status of the p53 tumor suppressor gene is a determinant of GSTP1 expression and mediates GSTP1-dependent drug resistance in human glioblastoma
2012
-
Bayesian Belief Network Mortality Analysis of a Breast Cancer Registry Data Set.
2011
-
P4-10-10: Breast Cancer Risk Factors among Asian Versus Caucasian Women with BRCA1/2 Mutations.
2011
-
P4-12-15: Cancer Survivor Care: An Evaluation of a Group Visit Model of Care for Breast Cancer Survivors at Duke Cancer Center.
2011
-
P5-13-17: Multigene Signature Assays in Patients with Early-Stage Breast Cancer (ESBC) Receiving Neoadjuvant Chemotherapy: An NCI-Funded Systematic Review and Evidence Summary of Predictive Performance.
2011
-
Abstract 1518: Gene expression profiling reveals acidosis/GPR4-induced inflammatory responses in vascular endothelial cells
2011
-
Abstract 3182: PTM ELISA microarray for breast cancer biomarker discovery
2011
-
Abstract 362: Comparison of Mig-6 and hormone receptor expression to BMI as predictors of responsiveness to progestin therapy for endometrial hyperplasia and cancer
2011
-
Abstract 387: Prostate cancer cell invasion is stimulated by cross communication with human monocyte-lineage cells
2011
-
Abstract 5377: A role for Ctr1 in the synergistic interaction between mild hyperthermia and cisplatin treatment
2011
-
Abstract 5569: The association between statin use and risk of biochemical recurrence in men treated with radical prostatectomy in a cohort of men with inherited forms of prostate cancer
2011
-
Profiling the effects of IDH1 and IDH2 mutants on the glioma cell metabolome
2011
-
Abstract PD06-09: Sentinel Node Biopsy Versus Axillary Lymph Node Dissection in Early-Stage Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
2010
-
Abstract LB-360: Fluorescence-based co-registration with protein markers reveals distinct cellular compartments for altered microRNA expression in solid tumors
2010
-
Abstract LB-76: A study of neoadjuvant bevacizumab with standard chemoradiation versus chemoradiation alone in locally advanced rectal cancer
2010
-
Feasibility of Preoperative Single Fraction Partial Breast Radiotherapy for Early Stage Breast Cancer
2009
-
Practice and Attitudes towards CYP2D6 Testing for Patients on Tamoxifen among US Oncologists
2009
-
: Apolipoprotein-E mimetic peptides mediate cytotoxicity in CLL: The role of PP2a and SET
2009
-
Apolipoprotein-E mimetic peptides mediate cytotoxicity in CLL: The role of PP2a and SET
2009
-
Complex hyperplasia with and without atypia - clinical outcomes and implications of progestin therapy in a 20 year cohort study of 1510 women
2009
-
Epidermal-specific expression of a CYLD mutant leads to increased sensitivity to skin carcinogenesis and metastasis
2009
-
Nuclear expression of transcription factors Stat5a and Stat5b confers favorable prognosis in breast cancer
2009
-
PP2A-dependent dephosphorylation of replication protein A (RPA) is required for the removal of DNA breaks induced by replication stress
2009
-
Podoplanin is a novel antibody-based therapeutic target for glioblastoma
2009
-
Role of lactate as a fuel in a unique microenvironmentally controlled metabolic symbiont
2009
-
Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling
2009
-
A phase II study to optimize dasatinib dosing in metastatic breast cancer patients using real-time pharmacodynamic tissue and urinary biomarkers
2009
-
A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer
2009
-
Antibody-based immunotherapy: targeting CSPG4 on human basal breast cancer stem cells
2009
-
Assays of circulating tumor cells and outcome in the triple-negative breast cancer trial TBCRC001.
2009
-
Survival outcome is similar for first-line chemotherapy with capecitabine or taxane for metastatic breast cancer
2009
-
Regulation of expression and role of the Pigment Epithelium Derived Factor in Ras-mediated oncogenesis
2009
-
The genomic analysis of lactic acidosis and acidosis response in human cancers
2009
-
Efficacy and immunologic effects of RNA-pulsed dendritic cell vaccines targeting human cytomegalovirus antigens in patients with glioblastoma
2008
-
A novel role of DNA fragmentation factor as a tumor suppressor through maintaining genetic stability
2006
-
Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk
2006
-
Characterization of membrane transport of the novel O-6-alkylguanine-DNA alkyltransferase inactivator, O-4-benzylfolic acid
2006
-
Characterization of the HSP70 co-chaperone HspBP1 in brain tumors
2006
-
Characterizing oligodendroglioma rearrangements using whole genome hrCGH arrays
2006
-
Combination therapy of bevacizumab with rapamycin in antitumor activity.
2006
-
Constitutive phosphorylation of Chk1 at serine 317 in a medulloblastoma cell line is sensitive to the inhibition of the phosphatidyalinositol-3-kinase-related kinase (PIKK) pathway
2006
-
Cytoplasmic tyrosine kinase c-Abl is required for bFGF but not VEGF-induced tumor angiogenesis
2006
-
Depletion of regulatory T cells increases the in vivo CEA specific T cell response
2006
-
Development of cellular models and small GTPases-targeted therapeutics for inflammatory breast cancer
2006
-
EGFR phosphorylates Glutathione S-Transferase P1 (GSTP1), a novel downstream target, in human glioma cells
2006
-
Effects of tumor tissue collagen content on the flow rate during intratumoral infusion
2006
-
Evaluation of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, KOS-1022) against Childhood Cancer Models by the Pediatric Preclinical Testing Program (PPTP)
2006
-
Frequent overexpression of prostate derived ets factor (PDEF) protein in breast cancer progression
2006
-
Genetic polymorphism of the Epidermal Growth Factor (EGF) gene in glioma patients: Distribution and correlation with Survival
2006
-
Identification of DNA copy number abnormalities associated with the metastatic phenotype of human breast cancer using a high resolution whole genome approach
2006
-
Identification of methylation hotspots in the GSTP1 region associated with transcriptional silencing of the GSTP1 gene in human gliomas
2006
-
Imaging alternative splicing in prostate tumors reveals mesenchymal-epithelial transitions in vivo
2006
-
Induction of Wilms' tumor protein (WT1)-specific immunity using a WT1-expressing adenovirus vaccine
2006
-
Molecular characterization of the role of OTX2 in medulloblastoma pathogenesis
2006
-
Molecular epidemiology of cyclin E overexpression in epithelial ovarian cancer
2006
-
O-6-alkylguanine-DNA alkyltransferase (AGT) and microsatellite instability (MSI) analyses in malignant glioma
2006
-
Overexpression of imprinted DLK1 in epithelial ovarian cancer
2006
-
Pharmacogenetics, molecular correlates and multiparameter high throughput evaluation of the response of inflamatory breast cancer cells to anticancer agents
2006
-
Polymorphisms of glutathione-S-transferase and N-acetyltransferase genes and response to treatment in childhood neuroblastoma
2006
-
Profiling of DNA copy number changes in sarcomas by array comparative genomic hybridization
2006
-
Prognostic significance of OTX2 in medulloblastoma
2006
-
Replication-competent packaging-deficient [E1+, 100k-] adenoviral vector-transduced dendritic cells can efficiently induce antigen-specific immune responses
2006
-
Secreted protein acidic and rich in cysteine (SPARC) activates focal adhesion kinase and integrin-linked kinase to induce AKT-dependent glioma survival and invasion
2006
-
Targeted approaches to the treatment of ovarian cancer.
2006
-
Targeted drug delivery for neuroblastoma using MIBG.
2006
-
Targeted drug delivery to solid tumors using thermally responsive elastin-like polypeptide macromolecular drug carriers
2006
-
Targeting of malignant gliomas with GPNMB-specific single-chain antibody fragment (scFv) and recombinant immunotoxin
2006
-
The tetraspanin superfamily member NET-6 is a new breast cancer suppressor gene
2006
-
Treatment with gleevec in NSCLC xenografts decreases proliferative capillary index and improves drug delivery
2006
-
YY1 imprint status and role in ovarian carcinogenesis
2006
-
Discovery of ovarian cancer tumor vascular markers using immuno-LCM and transcriptional profiling.
2006
-
Lysyl oxidase is essential for hypoxia-induced metastasis
2006
-
RADIOIMMUNOTHERAPY OF BREAST-CANCER XENOGRAFTS WITH MONOCLONAL-ANTIBODY ICR12 AGAINST C-ERBB2 P185 - COMPARISON OF IODOGEN AND N-SUCCINIMIDYL 4-METHYL-3-(TRI-N-BUTYLSTANNYL)BENZOATE RADIOIODINATION METHODS
1995